Header Logo

CURTIS A PETTAWAY

TitleProfessor
InstitutionMD Anderson
DepartmentUrology
Address1155 Pressler St
Houston TX 77030-3721
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Gregg JR, Newcomb L, Wu R, Dennison J, Davis JW, Pettaway C, Pisters L, Ward JF, Chapin BF, Ch?ry L, Urkmez A, Fang AM, Higgason N, Troncoso P, Daniel CR, Logothetis C, Thompson TC, Hahn AW, Liu M, Zheng Y, Lin DW, Hanash S, Irajizad E, Fahrmann J. Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance. Biomark Res. 2024 Nov 09; 12(1):134. PMID: 39522029; PMCID: PMC11550521.
      Citations:    
    2. Fang AM, Gregg JR, Pettaway C, Ma J, Szklaruk J, Bathala TK, Surasi DSS, Chapin BF. Whole-body MRI for staging prostate cancer: a narrative review. BJU Int. 2024 Sep 22. PMID: 39308142.
      Citations:    Fields:    
    3. Sotelo R, Sayegh AS, Medina LG, Perez LC, La Riva A, Eppler MB, Gaona J, Tobias-Machado M, Spiess PE, Pettaway CA, Lima Pompeo AC, Lima Mattos PA, Wilson TG, Villoldo GM, Chung E, Samaniego A, Ornellas AA, Pinheiro V, Braz?o ES, Subira-Rios D, Koifman L, Zequi SC, Pontillo Z HM, Rodrigues Calixto JR, Campos Silva R, Smithers BM, Garzon S, Haase O, Sommariva A, Fruscio R, Martins F, de Oliveira PS, Levi Sandri GB, Clementi M, Astigueta J, Metwally IH, Bharathan R, Jindal T, Nakamura Y, Abdel Mageed H, Jeevarajan S, Rodriguez Lay R, Garc?a-Perdomo HA, Rodr?guez Gonz?lez O, Ghodoussipour S, Gill I, Cacciamani GE. Complications and adverse events in lymphadenectomy of the inguinal area: worldwide expert consensus. BJS Open. 2024 Jul 02; 8(4). PMID: 38987232; PMCID: PMC11236483.
      Citations:    Translation:Humans
    4. Rose KM, Pham R, Zacharias NM, Ionescu F, Paravathaneni M, Marchetti KA, Sanchez D, Mustasam A, Sandstrom R, Vikram R, Dhillon J, Rao P, Schneider A, Pagliaro L, Alifrangis C, Albersen M, Roussel E, Master VA, Nazha B, Hernandez C, Moses KA, Protzel C, Montgomery J, Angel M, Tobias-Machado M, Spiess PE, Pettaway CA, Chahoud J, Rose KM, Pham R, Zacharias NM, Ionescu F, Paravathaneni M, Marchetti KA, Sanchez D, Mustasam A, Sandstrom R, Vikram R, Dhillon J, Rao P, Schneider A, Pagliaro L, Alifrangis C, Master VA, Nazha B, Hernandez C, Moses KA, Montgomery J, Spiess PE, Pettaway CA, Chahoud J. Neoadjuvant platinum-based chemotherapy and lymphadenectomy for penile cancer: an international, multi-institutional, real-world study. J Natl Cancer Inst. 2024 Jun 07; 116(6):966-973. PMID: 38366627.
      Citations:    Fields:    Translation:Humans
    5. Hahn AW, Manyam GC, Chapin BF, Zhang M, Yu Y, Pettaway CA, Chery L, Pisters LL, Ward JF, Gregg JR, Papadopoulos J, Kamat AM, Lozano M, Hoang A, Broom B, Wang X, Huff CD, Logothetis CJ, Troncoso P, Pili? PG, Davis JW. A phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlates. BJU Int. 2024 Sep; 134(3):449-458. PMID: 38837608.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    6. Zemp LW, Rudzinski JK, Pettaway CA, Nicholson S, Spiess PE. Management of Bulky Inguinal and Pelvic Lymph Nodes. Urol Clin North Am. 2024 Aug; 51(3):335-345. PMID: 38925736.
      Citations:    Fields:    Translation:Humans
    7. Garraway IP, Carlsson SV, Nyame YA, Vassy JL, Chilov M, Fleming M, Frencher SK, George DJ, Kibel AS, King SA, Kittles R, Mahal BA, Pettaway CA, Rebbeck T, Rose B, Vince R, Winn RA, Yamoah K, Oh WK. Prostate Cancer Foundation Screening Guidelines for Black Men in the United States. NEJM Evid. 2024 May; 3(5):EVIDoa2300289. PMID: 38815168.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    8. Cho D, Gor B, Hwang H, Wang X, Hernandez M, Jones LA, Frost J, Roberson P, Pettaway CA. A Community-Based Prostate Cancer Screening and Education Program for Asian American Men in Medically Underserved Communities. Int J Environ Res Public Health. 2024 Mar 28; 21(4). PMID: 38673327; PMCID: PMC11050265.
      Citations:    Fields:    Translation:HumansPHPublic Health
    9. Gu J, Chery L, Gonz?lez GMN, Huff C, Strom S, Jones JA, Griffith DP, Canfield SE, Wang X, Huang X, Roberson P, Meng QH, Troncoso P, Ittmann M, Covinsky M, Scheurer M, Irizarry Ramirez M, Pettaway CA. A west African ancestry-associated SNP on 8q24 predicts a positive biopsy in African American men with suspected prostate cancer following PSA screening. Prostate. 2024 May; 84(7):694-705. PMID: 38477020; PMCID: PMC11240849.
      Citations: 1     Fields:    Translation:Humans
    10. Zacharias NM, Segarra L, Akagi K, Fowlkes NW, Chen H, Alaniz A, de la Cerda C, Pesquera P, Xi Y, Wang J, Chahoud J, Lu X, Rao P, Martinez-Ferrer M, Pettaway CA. Transcriptomic, Proteomic, and Genomic Mutational Fraction Differences Based on HPV Status Observed in Patient-Derived Xenograft Models of Penile Squamous Cell Carcinoma. Cancers (Basel). 2024 Mar 06; 16(5). PMID: 38473423; PMCID: PMC10930474.
      Citations:    
    11. Ozambela M, McCormick BZ, Rudzinski JK, Pieretti AC, Gonz?lez GMN, Meissner MA, Papadopoulos JN, Adibi M, Matin SF, Dahmen AS, Spiess PE, Pettaway CA. Robotic or open superficial inguinal lymph node dissection as staging procedures for clinically node negative high risk penile cancer. Urol Oncol. 2024 04; 42(4):120.e1-120.e9. PMID: 38388244.
      Citations:    Fields:    Translation:Humans
    12. Gregg JR, Magill R, Fang AM, Chapin BF, Davis JW, Adibi M, Ch?ry L, Papadopoulos J, Pettaway C, Pisters L, Ward JF, Hahn AW, Daniel CR, Bhaskaran J, Zhu K, Guerrero M, Zhang M, Troncoso P. The association of body mass index with tumor aggression among men undergoing radical prostatectomy. Urol Oncol. 2024 04; 42(4):116.e1-116.e7. PMID: 38262868.
      Citations: 1     Fields:    Translation:Humans
    13. Pettaway CA. Editorial Comment. Urology. 2024 02; 184:155. PMID: 38228429.
      Citations:    Fields:    
    14. Vreeburg MTA, Donswijk ML, Albersen M, Parnham A, Ayres B, Protzel C, Pettaway C, Spiess PE, Brouwer OR. New EAU/ASCO guideline recommendations on sentinel node biopsy for penile cancer and remaining challenges from a nuclear medicine perspective. Eur J Nucl Med Mol Imaging. 2024 Aug; 51(10):2861-2868. PMID: 38216778.
      Citations:    Fields:    Translation:Humans
    15. Ionescu F, Nguyen J, Segura CM, Paravathaneni M, Grass GD, Johnstone P, Zacharias NM, Pettaway CA, Lu X, Kim Y, Whiting J, Dhillon J, Eschrich SA, Chadha J, Gullapalli K, Roman Souza G, Miyagi H, Manley BJ, Spiess PE, Chahoud J. Multiplex Immunofluorescence Captures Progressive Immune Exhaustion with Advancing Penile Squamous Cell Cancer Stage. Cancers (Basel). 2024 Jan 11; 16(2). PMID: 38275860; PMCID: PMC10814242.
      Citations: 1     
    16. Greco I, Fernandez-Pello S, Sakalis VI, Barreto L, Albersen M, Ayres B, Antunes Lopes T, Campi R, Crook J, Garc?a Perdomo HA, Johnstone PAS, Kailavasan M, Manzie K, Marcus JD, Necchi A, Oliveira P, Osborne J, Pagliaro LC, Parnham AS, Pettaway CA, Protzel C, Rumble RB, Sachdeva A, Sanchez Martinez DF, Zapala L, Tagawa ST, Spiess PE, Brouwer OR. Systematic Review and Meta-analysis of Minimally Invasive Procedures for Surgical Inguinal Nodal Staging in Penile Carcinoma. Eur Urol Focus. 2024 Jul; 10(4):567-580. PMID: 38071107.
      Citations: 1     Fields:    
    17. Zhuang TZ, Master V, Simon N, Flippot R, Buti S, Rodriguez PA, Castellano D, de Velasco G, Glover M, Adra N, Piedra A, Gernone A, Davis NB, Matthews H, Harrison MR, Kanesvaran R, Giudice GC, Barata P, Lee JL, Stahlfeld C, Freeman D, Apolo AB, El Zarif T, Nassar AH, Pond GR, Nazha B, Niglio S, Hahn AW, Pettaway CA, Tu SM, Abdel-Wahab N, Velev M, Maruzzo M, Mittra A, Gheeya J, Yang Y, Roviello G, Antonuzzo L, McKay RR, Vincenzi B, Cortellini A, Hui G, Drakaki A, Khaki AR, El-Am E, Mouhieddine TH, Patel V, Farolfi A, Milowsky MI, Appleman L, Kim JW, Choueiri TK, Spiess PE, Necchi A, Sonpavde GP. Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors. J Natl Cancer Inst. 2023 12 06; 115(12):1605-1615. PMID: 37563779; PMCID: PMC11032703.
      Citations: 3     Fields:    Translation:Humans
    18. Brouwer OR, Rumble RB, Ayres B, S?nchez Mart?nez DF, Oliveira P, Spiess PE, Johnstone PAS, Crook J, Pettaway CA, Tagawa ST, Members of the EAU-ASCO Penile Cancer Update Panel. Penile Cancer: EAU-ASCO Collaborative Guidelines Update Q and A. JCO Oncol Pract. 2024 01; 20(1):33-37. PMID: 37956391.
      Citations:    Fields:    Translation:Humans
    19. Elst L, Vreeburg MTA, de Vries HM, Vandermaesen K, Murphy T, Churchill J, Fallara G, Sanchez D, Falcone M, Garcia-Perdomo HA, Pettaway C, Hakenberg O, Johnstone P, Spiess PE, Muneer A, Sangar V, Parnham A, Ayres B, Watkin N, Brouwer OR, Albersen M. Corporal Skip Metastases in Penile Squamous Cell Carcinoma: An Unknown and Distinct Pattern of Spread with Poor Prognosis. Eur Urol Oncol. 2024 Jun; 7(3):478-484. PMID: 37813746.
      Citations:    Fields:    
    20. Parza K, Mustasam A, Ionescu F, Paravathaneni M, Sandstrom R, Safa H, Grass GD, Johnstone PA, Eschrich SA, Chadha J, Zacharias N, Pettaway CA, Spiess PE, Chahoud J. The Prognostic Role of Human Papillomavirus and p16 Status in Penile Squamous Cell Carcinoma-A Systematic Review. Cancers (Basel). 2023 Jul 21; 15(14). PMID: 37509374; PMCID: PMC10378259.
      Citations: 2     
    21. Morris VK, Jazaeri A, Westin SN, Pettaway C, George S, Huey RW, Grinsfelder M, Shafer A, Johnson B, Vining D, Guo M, Fellman B, Frumovitz M. Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated Cancers. Oncologist. 2023 07 05; 28(7):618-623. PMID: 37104874; PMCID: PMC10322132.
      Citations: 4     Fields:    Translation:HumansCellsCTClinical Trials
    22. May M, Lebentrau S, Watkin N, Albersen M, Protzel C, Chahoud J, Brouwer OR, Pettaway CA, Pagliaro LC, Necchi A, Hakenberg OW, Ayres B, Spiess PE. [Initial presentation of the Pentafecta score as a quality instrument for outcome evaluation of primary surgical treatment in patients with penile cancer]. Aktuelle Urol. 2023 08; 54(4):292-298. PMID: 37339668.
      Citations:    Fields:    Translation:Humans
    23. Sachdeva A, McGuinness L, Zapala L, Greco I, Garcia-Perdomo HA, Kailavasan M, Antunes-Lopes T, Ayres B, Barreto L, Campi R, Crook J, Johnstone P, Kumar V, Manzie K, Marcus JD, Necchi A, Oliveira P, Osborne J, Pagliaro LC, Protzel C, Bryan Rumble R, S?nchez Mart?nez DF, Spiess PE, Tagawa ST, van der Heijden MS, Parnham AS, Pettaway CA, Albersen M, Sangar VK, Brouwer OR, Sakalis VI. Management of Lymph Node-positive Penile Cancer: A Systematic Review. Eur Urol. 2024 Mar; 85(3):257-273. PMID: 37208237.
      Citations: 2     Fields:    Translation:Humans
    24. May M, Lebentrau S, Ayres B, Albersen M, Protzel C, Chahoud J, Brouwer OR, Pettaway CA, Pagliaro LC, Necchi A, Watkin N, Hakenberg OW, Spiess PE. The Goal of Achieving High-Quality Surgical First-Line Therapy in Patients with Penile Cancer Is Important; However, Some Collective Efforts Are Still Required in Order to Reach It. Comment on Brassetti et al. Combined Reporting of Surgical Quality and Cancer Control after Surgical Treatment for Penile Tumors with Inguinal Lymph Node Dissection: The Tetrafecta Achievement. Curr. Oncol. 2023, 30, 1882-1892. Curr Oncol. 2023 04 19; 30(4):4269-4274. PMID: 37185438; PMCID: PMC10136864.
      Citations:    Fields:    Translation:Humans
    25. Prakash G, Arora A, Bandini M, Basile G, Pal M, Griffiths G, Cornes R, Zhu Y, Rodriguez A, Alberson M, Necchi A, Master V, Pettaway CA, Spiess PE. Variations in Penile Cancer Management: Results From the Global Society of Rare Genitourinary Tumors Survey. Clin Genitourin Cancer. 2023 06; 21(3):376-382. PMID: 37037737.
      Citations:    Fields:    Translation:Humans
    26. Brouwer OR, Albersen M, Parnham A, Protzel C, Pettaway CA, Ayres B, Antunes-Lopes T, Barreto L, Campi R, Crook J, Fern?ndez-Pello S, Greco I, van der Heijden MS, Johnstone PAS, Kailavasan M, Manzie K, Marcus JD, Necchi A, Oliveira P, Osborne J, Pagliaro LC, Garcia-Perdomo HA, Rumble RB, Sachdeva A, Sakalis VI, Zapala L, S?nchez Mart?nez DF, Spiess PE, Tagawa ST. European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 Update. Eur Urol. 2023 06; 83(6):548-560. PMID: 36906413.
      Citations: 4     Fields:    Translation:Humans
    27. Siddiqui BA, Chapin BF, Jindal S, Duan F, Basu S, Yadav SS, Gu AD, Espejo AB, Kinder M, Pettaway CA, Ward JF, Tidwell RSS, Troncoso P, Corn PG, Logothetis CJ, Knoblauch R, Hutnick N, Gottardis M, Drake CG, Sharma P, Subudhi SK. Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor). J Immunother Cancer. 2023 03; 11(3). PMID: 36948506; PMCID: PMC10040066.
      Citations:    Fields:    Translation:HumansCells
    28. Chahoud J, Zacharias NM, Pham R, Qiao W, Guo M, Lu X, Alaniz A, Segarra L, Martinez-Ferrer M, Gleber-Netto FO, Pickering CR, Rao P, Pettaway CA. Prognostic Significance of p16 and Its Relationship with Human Papillomavirus Status in Patients with Penile Squamous Cell Carcinoma: Results of 5 Years Follow-Up. Cancers (Basel). 2022 Dec 07; 14(24). PMID: 36551510; PMCID: PMC9775956.
      Citations: 1     
    29. Ho J, Mattei J, Tetzlaff M, Williams MD, Davies MA, Diab A, Oliva ICG, McQuade J, Patel SP, Tawbi H, Wong MK, Fisher SB, Hanna E, Keung EZ, Ross M, Weiser R, Su SY, Frumovitz M, Meyer LA, Jazaeri A, Pettaway CA, Guadagnolo BA, Bishop AJ, Mitra D, Farooqi A, Bassett R, Faria S, Nagarajan P, Amaria RN. Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma. Front Oncol. 2022; 12:1001150. PMID: 36324592; PMCID: PMC9618687.
      Citations: 3     
    30. Giannone G, Giuliano AR, Bandini M, Marandino L, Raggi D, Earle W, Ayres B, Pettaway CA, McNeish IA, Spiess PE, Necchi A. HPV vaccination and HPV-related malignancies: impact, strategies and optimizations toward global immunization coverage. Cancer Treat Rev. 2022 Dec; 111:102467. PMID: 36265336.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    31. Joshi VB, Spiess PE, Necchi A, Pettaway CA, Chahoud J. Immune-based therapies in penile cancer. Nat Rev Urol. 2022 08; 19(8):457-474. PMID: 35851333.
      Citations:    Fields:    
    32. Sood A, Rudzinski JK, Spiess PE, Pettaway CA. The Acute Complications After Surgery for Penile Carcinoma and Strategies for Their Management: A Systematic Review of the Literature. Semin Oncol Nurs. 2022 06; 38(3):151285. PMID: 35597731.
      Citations:    Fields:    Translation:Humans
    33. Sakalis VI, Campi R, Barreto L, Perdomo HG, Greco I, Zapala L, Kailavasan M, Marcus JD, Manzie K, Osborne J, Ayres B, Moonen LMF, Necchi A, Crook J, Oliveira P, Pagliaro LC, Protzel C, Parnham AS, Albersen M, Pettaway CA, Spiess PE, Tagawa ST, Rumble RB, Brouwer OR, Antunes-Lopes T. What Is the Most Effective Management of the Primary Tumor in Men with Invasive Penile Cancer: A Systematic Review of the Available Treatment Options and Their Outcomes. Eur Urol Open Sci. 2022 Jun; 40:58-94. PMID: 35540709; PMCID: PMC9079254.
      Citations:    
    34. Pettaway CA, Spiess PE. Multimodality treatment of penile cancer: Part 2. Urol Oncol. 2022 06; 40(6):207-208. PMID: 35469703.
      Citations:    Fields:    Translation:Humans
    35. Pettaway CA, Spiess PE. Multimodality treatment of penile cancer: Part 1. Urol Oncol. 2022 05; 40(5):171-172. PMID: 35410775.
      Citations:    Fields:    Translation:Humans
    36. Kibbi N, Owen JL, Worley B, Wang JX, Harikumar V, Downing MB, Aasi SZ, Aung PP, Barker CA, Bolotin D, Bordeaux JS, Cartee TV, Chandra S, Cho NL, Choi JN, Chung KY, Cliby WA, Dorigo O, Eisen DB, Fujisawa Y, Golda N, Halfdanarson TR, Iavazzo C, Jiang SIB, Kanitakis J, Khan A, Kim JYS, Kuzel TM, Lawrence N, Leitao MM, MacLean AB, Maher IA, Mittal BB, Nehal KS, Ozog DM, Pettaway CA, Ross JS, Rossi AM, Servaes S, Solomon MJ, Thomas VD, Tolia M, Voelzke BB, Waldman A, Wong MK, Zhou Y, Arai N, Brackett A, Ibrahim SA, Kang BY, Poon E, Alam M. Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease. JAMA Oncol. 2022 04 01; 8(4):618-628. PMID: 35050310.
      Citations: 1     Fields:    Translation:Humans
    37. Nyame YA, Cooperberg MR, Cumberbatch MG, Eggener SE, Etzioni R, Gomez SL, Haiman C, Huang F, Lee CT, Litwin MS, Lyratzopoulos G, Mohler JL, Murphy AB, Pettaway C, Powell IJ, Sasieni P, Schaeffer EM, Shariat SF, Gore JL. Deconstructing, Addressing, and Eliminating Racial and Ethnic Inequities in Prostate Cancer Care. Eur Urol. 2022 10; 82(4):341-351. PMID: 35367082.
      Citations:    Fields:    
    38. Crook J, Black PC, Spiess PE, Pettaway C. The first International Penile Advanced Cancer Trial (InPACT) opens in Canada! Why additional centers are needed. Can Urol Assoc J. 2022 Feb; 16(2):70-71. PMID: 35133267; PMCID: PMC8932418.
      Citations:    
    39. Carmack CL, Parker NH, Demark-Wahnefried W, Shely L, Baum G, Yuan Y, Giordano SH, Rodriguez-Bigas M, Pettaway C, Basen-Engquist K. Healthy Moves to Improve Lifestyle Behaviors of Cancer Survivors and Their Spouses: Feasibility and Preliminary Results of Intervention Efficacy. Nutrients. 2021 Dec 14; 13(12). PMID: 34960013; PMCID: PMC8709140.
      Citations: 1     Fields:    Translation:Humans
    40. Hensley PJ, Bree KK, Guo CC, Lobo N, Campbell MT, Pettaway CA, Kamat AM. Clinicopathological analysis and outcomes of inflammatory myofibroblastic tumours of the urinary bladder. BJU Int. 2022 11; 130(5):604-610. PMID: 34773684.
      Citations:    Fields:    
    41. Xu Y, Tsai CW, Chang WS, Han Y, Huang M, Pettaway CA, Bau DT, Gu J. Epigenome-Wide Association Study of Prostate Cancer in African Americans Identifies DNA Methylation Biomarkers for Aggressive Disease. Biomolecules. 2021 12 03; 11(12). PMID: 34944472; PMCID: PMC8698937.
      Citations:    Fields:    Translation:HumansCells
    42. Jakobsen JK, Pettaway CA, Ayres B. Centralization and Equitable Care in Rare Urogenital Malignancies: The Case for Penile Cancer. Eur Urol Focus. 2021 09; 7(5):924-928. PMID: 34593356.
      Citations: 1     Fields:    Translation:Humans
    43. Shapiro DD, Davis JW, Williams WH, Chapin BF, Ward JF, Pettaway CA, Gregg JR. Increased body mass index is associated with operative difficulty during robot-assisted radical prostatectomy. BJUI Compass. 2022 Jan; 3(1):68-74. PMID: 35475154; PMCID: PMC8988518.
      Citations: 2     
    44. Bree KK, Hensley PJ, Pettaway CA. Germline Mutations in African American Men With Prostate Cancer: Incidence, Implications and Diagnostic Disparities. Urology. 2022 05; 163:148-155. PMID: 34453957.
      Citations:    Fields:    Translation:Humans
    45. Cho D, Milbury K, Liao Y, Pettaway CA, Gregg JR, Li Y, McNeill LH. Study protocol: One plus one can be greater than two-Ecological momentary assessment for Black prostate cancer survivors and partners. PLoS One. 2021; 16(8):e0255614. PMID: 34370761; PMCID: PMC8351991.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    46. Dahlstrom KR, Anderson KS, Guo M, Kwon MC, Messick CA, Pettaway CA, Asomaning N, Hopper M, Price A, Xu L, Day AT, Gillenwater AM, Sturgis EM. Screening for HPV-related oropharyngeal, anal, and penile cancers in middle-aged men: Initial report from the HOUSTON clinical trial. Oral Oncol. 2021 09; 120:105397. PMID: 34182223.
      Citations:    Fields:    Translation:HumansCells
    47. Bree KK, Hensley PJ, Pettaway CA. Germline Predisposition to Prostate Cancer in Diverse Populations. Urol Clin North Am. 2021 Aug; 48(3):411-423. PMID: 34210495.
      Citations:    Fields:    Translation:HumansCells
    48. Hahn AW, Chahoud J, Campbell MT, Karp DD, Wang J, Stephen B, Tu SM, Pettaway CA, Naing A. Pembrolizumab for advanced penile cancer: a case series from a phase II basket trial. Invest New Drugs. 2021 10; 39(5):1405-1410. PMID: 33770291.
      Citations: 7     Fields:    Translation:Humans
    49. Marilin N, Master VA, Pettaway CA, Spiess PE. Current practice patterns of society of urologic oncology members in performing inguinal lymph node staging/therapy for penile cancer: A survey study. Urol Oncol. 2021 07; 39(7):439.e9-439.e15. PMID: 33775532.
      Citations:    Fields:    Translation:Humans
    50. Graff M, Justice AE, Young KL, Marouli E, Zhang X, Fine RS, Lim E, Buchanan V, Rand K, Feitosa MF, Wojczynski MK, Yanek LR, Shao Y, Rohde R, Adeyemo AA, Aldrich MC, Allison MA, Ambrosone CB, Ambs S, Amos C, Arnett DK, Atwood L, Bandera EV, Bartz T, Becker DM, Berndt SI, Bernstein L, Bielak LF, Blot WJ, Bottinger EP, Bowden DW, Bradfield JP, Brody JA, Broeckel U, Burke G, Cade BE, Cai Q, Caporaso N, Carlson C, Carpten J, Casey G, Chanock SJ, Chen G, Chen M, Chen YI, Chen WM, Chesi A, Chiang CWK, Chu L, Coetzee GA, Conti DV, Cooper RS, Cushman M, Demerath E, Deming SL, Dimitrov L, Ding J, Diver WR, Duan Q, Evans MK, Falusi AG, Faul JD, Fornage M, Fox C, Freedman BI, Garcia M, Gillanders EM, Goodman P, Gottesman O, Grant SFA, Guo X, Hakonarson H, Haritunians T, Harris TB, Harris CC, Henderson BE, Hennis A, Hernandez DG, Hirschhorn JN, McNeill LH, Howard TD, Howard B, Hsing AW, Hsu YH, Hu JJ, Huff CD, Huo D, Ingles SA, Irvin MR, John EM, Johnson KC, Jordan JM, Kabagambe EK, Kang SJ, Kardia SL, Keating BJ, Kittles RA, Klein EA, Kolb S, Kolonel LN, Kooperberg C, Kuller L, Kutlar A, Lange L, Langefeld CD, Le Marchand L, Leonard H, Levin AM, Li Y, Li J, Liu Y, Liu Y, Liu S, Lohman K, Lotay V, Lu Y, Maixner W, Manson JE, McKnight B, Meng Y, Monda KL, Monroe K, Moore JH, Mosley TH, Mudgal P, Murphy AB, Nadukuru R, Nalls MA, Nathanson KL, Nayak U, Nemesure B, Neslund-Dudas C, Neuhouser ML, Nyante S, Ochs-Balcom H, Ogundiran TO, Ogunniyi A, Ojengbede O, Okut H, Olopade OI, Olshan A, Padhukasahasram B, Palmer J, Palmer CD, Palmer ND, Papanicolaou G, Patel SR, Pettaway CA, Peyser PA, Press MF, Rao DC, Rasmussen-Torvik LJ, Redline S, Reiner AP, Rhie SK, Rodriguez-Gil JL, Rotimi CN, Rotter JI, Ruiz-Narvaez EA, Rybicki BA, Salako B, Sale MM, Sanderson M, Schadt E, Schreiner PJ, Schurmann C, Schwartz AG, Shriner DA, Signorello LB, Singleton AB, Siscovick DS, Smith JA, Smith S, Speliotes E, Spitz M, Stanford JL, Stevens VL, Stram A, Strom SS, Sucheston L, Sun YV, Tajuddin SM, Taylor H, Taylor K, Tayo BO, Thun MJ, Tucker MA, Vaidya D, Van Den Berg DJ, Vedantam S, Vitolins M, Wang Z, Ware EB, Wassertheil-Smoller S, Weir DR, Wiencke JK, Williams SM, Williams LK, Wilson JG, Witte JS, Wrensch M, Wu X, Yao J, Zakai N, Zanetti K, Zemel BS, Zhao W, Zhao JH, Zheng W, Zhi D, Zhou J, Zhu X, Ziegler RG, Zmuda J, Zonderman AB, Psaty BM, Borecki IB, Cupples LA, Liu CT, Haiman CA, Loos R, Ng MCY, North KE, Lettre G, N'Diaye A. Discovery and fine-mapping of height loci via high-density imputation of GWASs in individuals of African ancestry. Am J Hum Genet. 2021 04 01; 108(4):564-582. PMID: 33713608; PMCID: PMC8059339.
      Citations: 7     Fields:    Translation:Humans
    51. Kokorovic A, Duplisea J, Qiao W, McCormick B, Adibi M, Papadopoulos J, Ramirez G, Rao P, Tamboli P, Pettaway C. Oncologic outcomes and subsequent treatment following organ sparing surgery for penile carcinoma: The University of Texas M.D. Anderson Cancer Center Experience. Urol Oncol. 2021 05; 39(5):302.e19-302.e27. PMID: 33612354.
      Citations: 1     Fields:    Translation:Humans
    52. Surasi DSS, Lu Y, Corn P, Pettaway C, Bathala T. Incidental Detection of Urothelial Carcinoma on 18F-Fluciclovine PET/CT. Clin Nucl Med. 2021 Feb 01; 46(2):e114-e115. PMID: 33156041.
      Citations:    Fields:    Translation:Humans
    53. Chahoud J, Gleber-Netto FO, McCormick BZ, Rao P, Lu X, Guo M, Morgan MB, Chu RA, Martinez-Ferrer M, Eterovic AK, Pickering CR, Pettaway CA. Whole-exome Sequencing in Penile Squamous Cell Carcinoma Uncovers Novel Prognostic Categorization and Drug Targets Similar to Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2021 05 01; 27(9):2560-2570. PMID: 33441293.
      Citations: 6     Fields:    Translation:Humans
    54. Shen X, Pettaway CA, Chen RC. Active Surveillance for Black Men With Low-Risk Prostate Cancer. JAMA. 2020 11 03; 324(17):1733-1734. PMID: 33141193.
      Citations: 4     Fields:    Translation:Humans
    55. Cho D, Basen-Engquist K, Acquati C, Pettaway C, Ma H, Markofski M, Li Y, Canfield SE, Gregg J, McNeill LH. Cultural Adaptation of Evidence-Based Lifestyle Interventions for African American Men With Prostate Cancer: A Dyadic Approach. Am J Mens Health. 2020 Nov-Dec; 14(6):1557988320945449. PMID: 33148111; PMCID: PMC7653295.
      Citations:    Fields:    Translation:Humans
    56. Tsai CW, Chang WS, Xu J, Xu Y, Huang M, Pettaway C, Bau DT, Gu J. Leukocyte telomere length is associated with aggressive prostate cancer in localized African American prostate cancer patients. Carcinogenesis. 2020 09 24; 41(9):1213-1218. PMID: 32614411.
      Citations: 3     Fields:    Translation:HumansCells
    57. Umbreit EC, McIntosh AG, Suk-Ouichai C, Segarra LA, Holland LC, Fellman BM, Williams SB, Thomas AZ, Tu SM, Pettaway CA, Pisters LL, Ward JF, Wood CG, Karam JA. Intraoperative and early postoperative complications in postchemotherapy retroperitoneal lymphadenectomy among patients with germ cell tumors using validated grading classifications. Cancer. 2020 11 15; 126(22):4878-4885. PMID: 32940929; PMCID: PMC9379780.
      Citations: 1     Fields:    Translation:Humans
    58. Cho D, Basen-Engquist K, Acquati C, Ma H, Pettaway C, Li Y, Diep CS, McNeill LH. Study protocol: a lifestyle intervention for African American and Hispanic prostate cancer survivors on active surveillance and their partners. Pilot Feasibility Stud. 2020; 6:111. PMID: 32782817; PMCID: PMC7414583.
      Citations:    
    59. Giri VN, Knudsen KE, Kelly WK, Cheng HH, Cooney KA, Cookson MS, Dahut W, Weissman S, Soule HR, Petrylak DP, Dicker AP, AlDubayan SH, Toland AE, Pritchard CC, Pettaway CA, Daly MB, Mohler JL, Parsons JK, Carroll PR, Pilarski R, Blanco A, Woodson A, Rahm A, Taplin ME, Polascik TJ, Helfand BT, Hyatt C, Morgans AK, Feng F, Mullane M, Powers J, Concepcion R, Lin DW, Wender R, Mark JR, Costello A, Burnett AL, Sartor O, Isaacs WB, Xu J, Weitzel J, Andriole GL, Beltran H, Briganti A, Byrne L, Calvaresi A, Chandrasekar T, Chen DYT, Den RB, Dobi A, Crawford ED, Eastham J, Eggener S, Freedman ML, Garnick M, Gomella PT, Handley N, Hurwitz MD, Izes J, Karnes RJ, Lallas C, Languino L, Loeb S, Lopez AM, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann M, Mille P, Miner MM, Morgan T, Moreno J, Mucci L, Myers RE, Nielsen SM, O'Neil B, Pinover W, Pinto P, Poage W, Raj GV, Rebbeck TR, Ryan C, Sandler H, Schiewer M, Scott EMD, Szymaniak B, Tester W, Trabulsi EJ, Vapiwala N, Yu EY, Zeigler-Johnson C, Gomella LG. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019. J Clin Oncol. 2020 08 20; 38(24):2798-2811. PMID: 32516092; PMCID: PMC7430215.
      Citations: 54     Fields:    Translation:Humans
    60. Huang T, Cheng X, Chahoud J, Sarhan A, Tamboli P, Rao P, Guo M, Manyam G, Zhang L, Xiang Y, Han L, Shang X, Deng P, Luo Y, Lu X, Feng S, Ferrer MM, Alan Wang Y, DePinho RA, Pettaway CA, Lu X. Effective combinatorial immunotherapy for penile squamous cell carcinoma. Nat Commun. 2020 05 01; 11(1):2124. PMID: 32358507; PMCID: PMC7195486.
      Citations: 12     Fields:    Translation:HumansAnimalsCells
    61. Gregg JR, Davis JW, Reichard C, Wang X, Achim M, Chapin BF, Pisters L, Pettaway C, Ward JF, Choi S, Nguyen QN, Kuban D, Babaian R, Troncoso P, Madsen LT, Logothetis C, Kim J. Determining Clinically Based Factors Associated With Reclassification in the Pre-MRI Era using a Large Prospective Active Surveillance Cohort. Urology. 2020 04; 138:91-97. PMID: 31899230; PMCID: PMC7141963.
      Citations: 2     Fields:    Translation:Humans
    62. Tang C, Hoffman KE, Allen PK, Gabel M, Schreiber D, Choi S, Chapin BF, Nguyen QN, Davis JW, Corn P, Logothetis C, Ward J, Frank SJ, Navai N, McGuire SE, Anscher M, Pisters L, Pettaway CA, Kumar R, Linson P, Tripuraneni P, Tomaszewski JJ, Patel AB, Augspurger M, Kuban DA. Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends. Cancer. 2020 02 01; 126(3):506-514. PMID: 31742674; PMCID: PMC6980273.
      Citations: 7     Fields:    Translation:Humans
    63. Pettaway CA. African American and Asian males: what do we know about germline predisposition to prostate cancer. Can J Urol. 2019 Oct; 26(5 Suppl 2):27-28. PMID: 31629423.
      Citations: 1     Fields:    Translation:Humans
    64. Xu J, Tsai CW, Chang WS, Han Y, Bau DT, Pettaway CA, Gu J. Methylation of global DNA repeat LINE-1 and subtelomeric DNA repeats D4Z4 in leukocytes is associated with biochemical recurrence in African American prostate cancer patients. Carcinogenesis. 2019 Sep 18; 40(9):1055-1060. PMID: 30874286.
      Citations: 2     Fields:    
    65. Chahoud J, Pickering CR, Pettaway CA. Genetics and penile cancer: recent developments and implications. Curr Opin Urol. 2019 07; 29(4):364-370. PMID: 31045928.
      Citations: 9     Fields:    Translation:Humans
    66. Canter DJ, Nicholson S, Watkin N, Hall E, Pettaway C, InPACT Executive Committee. The International Penile Advanced Cancer Trial (InPACT): Rationale and Current Status. Eur Urol Focus. 2019 Sep; 5(5):706-709. PMID: 31160252.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    67. Mauzo SH, Tetzlaff MT, Siroy AE, Nagarajan P, Torres-Cabala CA, Ivan D, Curry JL, Hudgens CW, Wargo JA, Sahin AA, Pettaway CA, Prieto VG, Aung PP, Milton DR. Expression of PD-1 and PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted Therapy. Cancers (Basel). 2019 May 29; 11(6). PMID: 31146499; PMCID: PMC6627796.
      Citations: 10     
    68. Wong M, Bierman Y, Pettaway C, Kittles R, Mims M, Jones J, Ittmann M. Comparative analysis of p16 expression among African American and European American prostate cancer patients. Prostate. 2019 08; 79(11):1274-1283. PMID: 31111520; PMCID: PMC6617792.
      Citations: 3     Fields:    Translation:Humans
    69. Pettaway CA. Penile Cancer Management in the United States: Regional Centers of Expertise are Needed! Ann Surg Oncol. 2019 Apr; 26(4):928-929. PMID: 30684158.
      Citations: 1     Fields:    Translation:Humans
    70. Lairson DR, Wu CF, Chan W, Fu S, Hoffman KE, Pettaway CA. Mean treatment cost of incident cases of penile cancer for privately insured patients in the United States. Urol Oncol. 2019 04; 37(4):294.e17-294.e25. PMID: 30660492.
      Citations: 1     Fields:    Translation:Humans
    71. Altok M, Kim B, Patel BB, Shih YT, Ward JF, McRae SE, Chapin BF, Pisters LL, Pettaway CA, Kim J, Demirel HC, Davis JW. Cost and efficacy comparison of five prostate biopsy modalities: a platform for integrating cost into novel-platform comparative research. Prostate Cancer Prostatic Dis. 2018 11; 21(4):524-532. PMID: 29988098.
      Citations: 13     Fields:    Translation:Humans
    72. McCormick B, Pettaway C. Insights Into the Management of Lymph Node-Positive Penile Cancer. JAMA Oncol. 2018 05 01; 4(5):650-651. PMID: 29494734.
      Citations: 1     Fields:    Translation:Humans
    73. Reichard CA, Gregg JR, Achim MF, Aparicio AM, Pettaway CA, Pisters LL, Ward JF, Davis JW, Chapin BF. Radical Prostatectomy in Metastatic Castration-resistant Prostate Cancer: Feasibility, Safety, and Quality of Life Outcomes. Eur Urol. 2018 08; 74(2):140-143. PMID: 29656854.
      Citations: 5     Fields:    Translation:Humans
    74. Pettaway CA. Editorial Comment. J Urol. 2018 06; 199(6):1524-1525. PMID: 29601784.
      Citations:    Fields:    Translation:Humans
    75. Giri VN, Knudsen KE, Kelly WK, Abida W, Andriole GL, Bangma CH, Bekelman JE, Benson MC, Blanco A, Burnett A, Catalona WJ, Cooney KA, Cooperberg M, Crawford DE, Den RB, Dicker AP, Eggener S, Fleshner N, Freedman ML, Hamdy FC, Hoffman-Censits J, Hurwitz MD, Hyatt C, Isaacs WB, Kane CJ, Kantoff P, Karnes RJ, Karsh LI, Klein EA, Lin DW, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann MJ, Mark JR, McCue PA, Miner MM, Morgan T, Moul JW, Myers RE, Nielsen SM, Obeid E, Pavlovich CP, Peiper SC, Penson DF, Petrylak D, Pettaway CA, Pilarski R, Pinto PA, Poage W, Raj GV, Rebbeck TR, Robson ME, Rosenberg MT, Sandler H, Sartor O, Schaeffer E, Schwartz GF, Shahin MS, Shore ND, Shuch B, Soule HR, Tomlins SA, Trabulsi EJ, Uzzo R, Vander Griend DJ, Walsh PC, Weil CJ, Wender R, Gomella LG. Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017. J Clin Oncol. 2018 02 01; 36(4):414-424. PMID: 29236593; PMCID: PMC6075860.
      Citations: 58     Fields:    Translation:Humans
    76. Blanchard P, Davis JW, Frank SJ, Kim J, Pettaway CA, Pugh TJ, Pisters LL, Ward JF, Choi S, Chapin BF, Hoffman K, Navai N, Achim M, McGuire SE, Matin SF, Nguyen Q, Mahmood U, Graber WJ, Chen HC, Wang X, Kuban DA. Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort. BJU Int. 2018 04; 121(4):540-548. PMID: 28941030.
      Citations: 8     Fields:    Translation:Humans
    77. Altok M, Achim MF, Matin SF, Pettaway CA, Chapin BF, Davis JW. A decade of robot-assisted radical prostatectomy training: Time-based metrics and qualitative grading for fellows and residents. Urol Oncol. 2018 01; 36(1):13.e19-13.e25. PMID: 28964658.
      Citations: 2     Fields:    Translation:Humans
    78. Zhang M, Adeniran AJ, Vikram R, Tamboli P, Pettaway C, Bondaruk J, Liu J, Baggerly K, Czerniak B. Carcinoma of the urethra. Hum Pathol. 2018 02; 72:35-44. PMID: 28827100; PMCID: PMC5975388.
      Citations: 6     Fields:    Translation:HumansCells
    79. Basourakos SP, Davis JW, Chapin BF, Ward JF, Pettaway CA, Pisters LL, Navai N, Achim MF, Wang X, Chen HC, Choi S, Kuban D, Troncoso P, Hanash S, Thompson TC, Kim J. Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancer. BJU Int. 2018 01; 121(1):69-76. PMID: 28710901; PMCID: PMC6126916.
      Citations: 6     Fields:    Translation:Humans
    80. Pettaway CA. Usefulness of Mapping Biopsy in the Treatment of Penoscrotal Extramammary Paget's Disease. Ann Surg Oncol. 2017 10; 24(11):3115. PMID: 28634665.
      Citations:    Fields:    Translation:Humans
    81. Kittles RA, Wang X, Salgado-Montilla J, Guerrios L, Rivera K, Shah E, Prokhorova I, Roberson P, Troncoso P, Pettaway CA, Irizarry-Ram?rez M, Nogueras-Gonz?lez GM, S?nchez-Ortiz R. Genetic ancestry and prostate cancer susceptibility SNPs in Puerto Rican and African American men. Prostate. 2017 Jul; 77(10):1118-1127. PMID: 28543179; PMCID: PMC5495141.
      Citations: 8     Fields:    Translation:Humans
    82. Sundi D, Schaeffer E, Pettaway C, G?kce MI. Is active surveillance a suitable option for African American men with prostate cancer? A systemic literature review. Prostate Cancer Prostatic Dis. 2017 06; 20(2):127-136. PMID: 28417980.
      Citations: 13     Fields:    Translation:Humans
    83. Leone A, Diorio GJ, Pettaway C, Master V, Spiess PE. Contemporary management of patients with penile cancer and lymph node metastasis. Nat Rev Urol. 2017 Jun; 14(6):335-347. PMID: 28401957.
      Citations: 23     Fields:    Translation:Humans
    84. Gao J, Ward JF, Pettaway CA, Shi LZ, Subudhi SK, Vence LM, Zhao H, Chen J, Chen H, Efstathiou E, Troncoso P, Allison JP, Logothetis CJ, Wistuba II, Sepulveda MA, Sun J, Wargo J, Blando J, Sharma P. VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer. Nat Med. 2017 May; 23(5):551-555. PMID: 28346412; PMCID: PMC5466900.
      Citations: 199     Fields:    Translation:HumansAnimalsCells
    85. Gilani S, Guo CC, Li-Ning EM, Pettaway C, Troncoso P. Transformation of prostatic adenocarcinoma to well-differentiated neuroendocrine tumor after hormonal treatment. Hum Pathol. 2017 06; 64:186-190. PMID: 28159676.
      Citations: 3     Fields:    Translation:Humans
    86. Bernard B, Muralidhar V, Chen YH, Sridhar SS, Mitchell EP, Pettaway CA, Carducci MA, Nguyen PL, Sweeney CJ. Impact of ethnicity on the outcome of men with metastatic, hormone-sensitive prostate cancer. Cancer. 2017 May 01; 123(9):1536-1544. PMID: 28055108; PMCID: PMC5400707.
      Citations: 15     Fields:    Translation:Humans
    87. Pettaway CA. Editorial Comment. J Urol. 2017 03; 197(3 Pt 1):696-697. PMID: 27936384.
      Citations:    Fields:    
    88. Reddy JP, Pettaway CA, Levy LB, Pagliaro LC, Tamboli P, Rao P, Jayaratna I, Hoffman KE. Factors associated with regional recurrence after lymph node dissection for penile squamous cell carcinoma. BJU Int. 2017 04; 119(4):591-597. PMID: 27753187.
      Citations: 7     Fields:    Translation:Humans
    89. Wang X, Frost J, Roberson P, Volk RJ, Brooks D, Canfield SE, Pettaway CA, G?kce MI. Informed decision making before prostate-specific antigen screening: Initial results using the American Cancer Society (ACS) Decision Aid (DA) among medically underserved men. Cancer. 2017 02 15; 123(4):583-591. PMID: 27727462; PMCID: PMC5293675.
      Citations: 8     Fields:    Translation:Humans
    90. Sharma P, Zargar-Shoshtari K, Pettaway CA, Schabath MB, Giuliano AR, Spiess PE. Disparities in Penile Cancer. Cancer Control. 2016 Oct; 23(4):409-414. PMID: 27842330.
      Citations: 5     Fields:    Translation:Humans
    91. Zhang M, Pettaway C, Vikram R, Tamboli P. Adenoid cystic carcinoma of the urethra/Cowper's gland with concurrent high-grade prostatic adenocarcinoma: a detailed clinicopathologic case report and review of the literature. Hum Pathol. 2016 12; 58:138-144. PMID: 27554206.
      Citations: 3     Fields:    Translation:Humans
    92. Crawford ED, Rosenberg MT, Partin AW, Cooperberg MR, Maccini M, Loeb S, Pettaway CA, Shore ND, Arangua P, Hoenemeyer J, Leveridge M, Leapman M, Pinto P, Thompson IM, Carroll P, Eastham J, Gomella L, Klein EA. An Approach Using PSA Levels of 1.5?ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care. Urology. 2016 Oct; 96:116-120. PMID: 27450937; PMCID: PMC5568096.
      Citations: 4     Fields:    Translation:Humans
    93. Ashorobi OS, Frost J, Wang X, Roberson P, Lin E, Volk RJ, Lopez DS, Jones LA, Pettaway CA. Prostate Cancer Education, Detection, and Follow-Up in a Community-Based Multiethnic Cohort of Medically Underserved Men. Am J Mens Health. 2017 Jan; 11(1):82-91. PMID: 25986045; PMCID: PMC4967034.
      Citations: 5     Fields:    
    94. Kenney PA, Nawaf CB, Mustafa M, Wen S, Wszolek MF, Pettaway CA, Ward JF, Davis JW, Pisters LL. Robotic-assisted laparoscopic versus open salvage radical prostatectomy following radiotherapy. Can J Urol. 2016 Jun; 23(3):8271-7. PMID: 27347619; PMCID: PMC5512888.
      Citations: 10     Fields:    Translation:Humans
    95. Zhang T, Tseng C, Zhang Y, Sirin O, Corn PG, Li-Ning-Tapia EM, Troncoso P, Davis J, Pettaway C, Ward J, Frazier ML, Logothetis C, Kolonin MG. CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment. Nat Commun. 2016 05 31; 7:11674. PMID: 27241286; PMCID: PMC4895055.
      Citations: 72     Fields:    Translation:HumansAnimalsCells
    96. Gusev A, Shi H, Kichaev G, Pomerantz M, Li F, Long HW, Ingles SA, Kittles RA, Strom SS, Rybicki BA, Nemesure B, Isaacs WB, Zheng W, Pettaway CA, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Chokkalingam AP, John EM, Murphy AB, Signorello LB, Carpten J, Leske MC, Wu SY, Hennis AJ, Neslund-Dudas C, Hsing AW, Chu L, Goodman PJ, Klein EA, Witte JS, Casey G, Kaggwa S, Cook MB, Stram DO, Blot WJ, Eeles RA, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Southey MC, Fitzgerald LM, Gronberg H, Wiklund F, Aly M, Henderson BE, Schleutker J, Wahlfors T, Tammela TL, Key TJ, Travis RC, Neal DE, Donovan JL, Hamdy FC, Pharoah P, Pashayan N, Khaw KT, Stanford JL, Thibodeau SN, McDonnell SK, Schaid DJ, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Wokolorczyk D, Kluzniak W, Cannon-Albright L, Teerlink C, Brenner H, Dieffenbach AK, Arndt V, Park JY, Sellers TA, Lin HY, Slavov C, Kaneva R, Mitev V, Batra J, Spurdle A, Clements JA, Teixeira MR, Pandha H, Michael A, Paulo P, Maia S, Kierzek A, PRACTICAL consortium, Conti DV, Albanes D, Berg C, Berndt SI, Campa D, Crawford ED, Diver WR, Gapstur SM, Gaziano JM, Giovannucci E, Hoover R, Hunter DJ, Johansson M, Kraft P, Le Marchand L, Navarro C, Overvad K, Riboli E, Siddiq A, Stevens VL, Trichopoulos D, Vineis P, Yeager M, Trynka G, Raychaudhuri S, Schumacher FR, Price AL, Freedman ML, Haiman CA, Pasaniuc B, Nordestgaard BG, Lindstr?m S. Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation. Nat Commun. 2016 Apr 07; 7:10979. PMID: 27052111; PMCID: PMC4829663.
      Citations: 31     Fields:    Translation:HumansCells
    97. Kim J, Davis JW, Klein EA, Magi-Galluzzi C, Lotan Y, Ward JF, Pisters LL, Basler JW, Pettaway CA, Stephenson A, Li Ning Tapia EM, Efstathiou E, Wang X, Do KA, Lee JJ, Gorlov IP, Vornik LA, Hoque AM, Prokhorova IN, Parnes HL, Lippman SM, Thompson IM, Brown PH, Logothetis CJ, Troncoso P. Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate Cancer. EBioMedicine. 2016 May; 7:85-93. PMID: 27322462; PMCID: PMC4909608.
      Citations: 2     Fields:    Translation:Humans
    98. Pettaway CA. Editorial Comment. Urology. 2016 Apr; 90:88. PMID: 27036679.
      Citations:    Fields:    Translation:Humans
    99. Han Y, Rand KA, Hazelett DJ, Ingles SA, Kittles RA, Strom SS, Rybicki BA, Nemesure B, Isaacs WB, Stanford JL, Zheng W, Schumacher FR, Berndt SI, Wang Z, Xu J, Rohland N, Reich D, Tandon A, Pasaniuc B, Allen A, Quinque D, Mallick S, Notani D, Rosenfeld MG, Jayani RS, Kolb S, Gapstur SM, Stevens VL, Pettaway CA, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Chokkalingam AP, John EM, Murphy AB, Signorello LB, Carpten J, Leske MC, Wu SY, Hennis AJM, Neslund-Dudas C, Hsing AW, Chu L, Goodman PJ, Klein EA, Zheng SL, Witte JS, Casey G, Lubwama A, Pooler LC, Sheng X, Coetzee GA, Cook MB, Chanock SJ, Stram DO, Watya S, Blot WJ, Conti DV, Henderson BE, Haiman CA. Prostate Cancer Susceptibility in Men of African Ancestry at 8q24. J Natl Cancer Inst. 2016 Jul; 108(7). PMID: 26823525; PMCID: PMC4948565.
      Citations: 61     Fields:    Translation:HumansCells
    100. Williams SB, Davis JW, Wang X, Achim MF, Zurita-Saavedra A, Matin SF, Pisters LL, Ward JF, Pettaway CA, Chapin BF. Neoadjuvant Systemic Therapy Before Radical Prostatectomy in High-Risk Prostate Cancer Does Not Increase Surgical Morbidity: Contemporary Results Using the Clavien System. Clin Genitourin Cancer. 2016 Apr; 14(2):130-8. PMID: 26558524.
      Citations: 4     Fields:    Translation:Humans
    101. Pantuck AJ, Pettaway CA, Dreicer R, Corman J, Katz A, Ho A, Aronson W, Clark W, Simmons G, Heber D. A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancer. Prostate Cancer Prostatic Dis. 2015 Sep; 18(3):242-8. PMID: 26169045.
      Citations: 18     Fields:    Translation:HumansAnimalsCTClinical Trials
    102. Han Y, Hazelett DJ, Wiklund F, Schumacher FR, Stram DO, Berndt SI, Wang Z, Rand KA, Hoover RN, Machiela MJ, Yeager M, Burdette L, Chung CC, Hutchinson A, Yu K, Xu J, Travis RC, Key TJ, Siddiq A, Canzian F, Takahashi A, Kubo M, Stanford JL, Kolb S, Gapstur SM, Diver WR, Stevens VL, Strom SS, Pettaway CA, Al Olama AA, Kote-Jarai Z, Eeles RA, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Chokkalingam AP, Isaacs WB, Chen C, Lindstrom S, Le Marchand L, Giovannucci EL, Pomerantz M, Long H, Li F, Ma J, Stampfer M, John EM, Ingles SA, Kittles RA, Murphy AB, Blot WJ, Signorello LB, Zheng W, Albanes D, Virtamo J, Weinstein S, Nemesure B, Carpten J, Leske MC, Wu SY, Hennis AJ, Rybicki BA, Neslund-Dudas C, Hsing AW, Chu L, Goodman PJ, Klein EA, Zheng SL, Witte JS, Casey G, Riboli E, Li Q, Freedman ML, Hunter DJ, Gronberg H, Cook MB, Nakagawa H, Kraft P, Chanock SJ, Easton DF, Henderson BE, Coetzee GA, Conti DV, Haiman CA. Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions. Hum Mol Genet. 2015 Oct 01; 24(19):5603-18. PMID: 26162851; PMCID: PMC4572069.
      Citations: 24     Fields:    Translation:Humans
    103. Davis JW, Ward JF, Pettaway CA, Wang X, Kuban D, Frank SJ, Lee AK, Pisters LL, Matin SF, Shah JB, Karam JA, Chapin BF, Papadopoulos JN, Achim M, Hoffman KE, Pugh TJ, Choi S, Troncoso P, Logothetis CJ, Kim J. Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance. BJU Int. 2016 07; 118(1):68-76. PMID: 26059275; PMCID: PMC4808616.
      Citations: 17     Fields:    Translation:Humans
    104. Dickstein RJ, Munsell MF, Pagliaro LC, Pettaway CA. Prognostic factors influencing survival from regionally advanced squamous cell carcinoma of the penis after preoperative chemotherapy. BJU Int. 2016 Jan; 117(1):118-25. PMID: 25294319.
      Citations: 11     Fields:    Translation:Humans
    105. Zurita AJ, Pisters LL, Wang X, Troncoso P, Dieringer P, Ward JF, Davis JW, Pettaway CA, Logothetis CJ, Pagliaro LC. Integrating chemohormonal therapy and surgery in known or suspected lymph node metastatic prostate cancer. Prostate Cancer Prostatic Dis. 2015 Sep; 18(3):276-80. PMID: 26171883; PMCID: PMC4821010.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    106. Wang J, Pettaway CA, Pagliaro LC. Treatment for Metastatic Penile Cancer After First-line Chemotherapy Failure: Analysis of Response and Survival Outcomes. Urology. 2015 May; 85(5):1104-1110. PMID: 25819619.
      Citations: 18     Fields:    Translation:Humans
    107. Wang J, Pettaway CA, Pagliaro LC. Reply: To PMID 25819619. Urology. 2015 May; 85(5):1110. PMID: 25819623.
      Citations:    Fields:    Translation:Humans
    108. Pettaway CA. Editorial comment. Urology. 2015 May; 85(5):1101-1102. PMID: 25769779.
      Citations:    Fields:    Translation:Humans
    109. Mustafa M, Pettaway CA, Davis JW, Pisters L. Robotic or open radical prostatectomy after previous open surgery in the pelvic region. Korean J Urol. 2015 Feb; 56(2):131-7. PMID: 25685300; PMCID: PMC4325117.
      Citations: 2     Fields:    Translation:Humans
    110. Bogaerts J, Sydes MR, Keat N, McConnell A, Benson A, Ho A, Roth A, Fortpied C, Eng C, Peckitt C, Coens C, Pettaway C, Arnold D, Hall E, Marshall E, Sclafani F, Hatcher H, Earl H, Paul J, Whelan J, Panageas K, Wheatley K, Harrington K, Licitra L, Billingham L, Hensley M, McCabe M, Patel PM, Carvajal R, Wilson R, Glynne-Jones R, McWilliams R, Leyvraz S, Rao S, Nicholson S, Filiaci V, Negrouk A, Lacombe D, Dupont E, Welch JJ, Law K, Trimble T, Seymour M, Ray-Coquard I, Blay JY, Pauport? I. Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative. Eur J Cancer. 2015 Feb; 51(3):271-81. PMID: 25542058; PMCID: PMC4639696.
      Citations: 40     Fields:    Translation:Humans
    111. Culp SH, Pettaway CA. Penile cancer: new insights into the "way forward" for this rare disease. J Urol. 2015 Feb; 193(2):394-5. PMID: 25447102.
      Citations:    Fields:    Translation:Humans
    112. Al Olama AA, Kote-Jarai Z, Berndt SI, Conti DV, Schumacher F, Han Y, Benlloch S, Hazelett DJ, Wang Z, Saunders E, Leongamornlert D, Lindstrom S, Jugurnauth-Little S, Dadaev T, Tymrakiewicz M, Stram DO, Rand K, Wan P, Stram A, Sheng X, Pooler LC, Park K, Xia L, Tyrer J, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Yeager M, Burdette L, Chung CC, Hutchinson A, Yu K, Goh C, Ahmed M, Govindasami K, Guy M, Tammela TL, Auvinen A, Wahlfors T, Schleutker J, Visakorpi T, Leinonen KA, Xu J, Aly M, Donovan J, Travis RC, Key TJ, Siddiq A, Canzian F, Khaw KT, Takahashi A, Kubo M, Pharoah P, Pashayan N, Weischer M, Nordestgaard BG, Nielsen SF, Klarskov P, Iversen P, Thibodeau SN, McDonnell SK, Schaid DJ, Stanford JL, Kolb S, Holt S, Knudsen B, Coll AH, Gapstur SM, Diver WR, Stevens VL, Maier C, Luedeke M, Rinckleb AE, Strom SS, Pettaway C, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Chokkalingam AP, Cannon-Albright L, Cybulski C, Wokolorczyk D, Kluzniak W, Park J, Sellers T, Lin HY, Isaacs WB, Partin AW, Brenner H, Dieffenbach AK, Chen C, Giovannucci EL, Ma J, Stampfer M, Penney KL, Mucci L, John EM, Ingles SA, Kittles RA, Murphy AB, Pandha H, Michael A, Kierzek AM, Blot W, Signorello LB, Zheng W, Albanes D, Virtamo J, Weinstein S, Nemesure B, Carpten J, Leske C, Wu SY, Hennis A, Kibel AS, Rybicki BA, Neslund-Dudas C, Hsing AW, Chu L, Goodman PJ, Klein EA, Zheng SL, Batra J, Clements J, Spurdle A, Teixeira MR, Paulo P, Maia S, Slavov C, Kaneva R, Mitev V, Witte JS, Casey G, Gillanders EM, Seminara D, Riboli E, Hamdy FC, Coetzee GA, Li Q, Freedman ML, Hunter DJ, Muir K, Gronberg H, Neal DE, Southey M, Giles GG, Severi G, Breast and Prostate Cancer Cohort Consortium (BPC3), PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Gen, COGS (Collaborative Oncological Gene-environment Study) Consortium, GAME-ON/ELLIPSE Consortium, Cook MB, Nakagawa H, Wiklund F, Kraft P, Chanock SJ, Henderson BE, Easton DF, Eeles RA, Haiman CA, R?der MA, Herkommer K, Stegmaier C. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nat Genet. 2014 Oct; 46(10):1103-9. PMID: 25217961; PMCID: PMC4383163.
      Citations: 229     Fields:    Translation:Humans
    113. Han Y, Signorello LB, Strom SS, Kittles RA, Rybicki BA, Stanford JL, Goodman PJ, Berndt SI, Carpten J, Casey G, Chu L, Conti DV, Rand KA, Diver WR, Hennis AJ, John EM, Kibel AS, Klein EA, Kolb S, Le Marchand L, Leske MC, Murphy AB, Neslund-Dudas C, Park JY, Pettaway C, Rebbeck TR, Gapstur SM, Zheng SL, Wu SY, Witte JS, Xu J, Isaacs W, Ingles SA, Hsing A, PRACTICAL Consortium, ELLIPSE GAME-ON Consortium, Easton DF, Eeles RA, Schumacher FR, Chanock S, Nemesure B, Blot WJ, Stram DO, Henderson BE, Haiman CA. Generalizability of established prostate cancer risk variants in men of African ancestry. Int J Cancer. 2015 Mar 01; 136(5):1210-7. PMID: 25044450; PMCID: PMC4268262.
      Citations: 33     Fields:    Translation:Humans
    114. Madsen LT, Kuban DA, Choi S, Davis JW, Kim J, Lee AK, Domain D, Levy L, Pisters LL, Pettaway CA, Ward JF, Logothetis C, Hoffman KE. Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinic. J Natl Compr Canc Netw. 2014 Jul; 12(7):993-8. PMID: 24994920; PMCID: PMC4413899.
      Citations: 3     Fields:    Translation:Humans
    115. Carthon BC, Ng CS, Pettaway CA, Pagliaro LC. Epidermal growth factor receptor-targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis. BJU Int. 2014 Jun; 113(6):871-7. PMID: 24053151; PMCID: PMC4321685.
      Citations: 28     Fields:    Translation:Humans
    116. Kharadjian TB, Matin SF, Pettaway CA. Early experience of robotic-assisted inguinal lymphadenectomy: review of surgical outcomes relative to alternative approaches. Curr Urol Rep. 2014 Jun; 15(6):412. PMID: 24756453.
      Citations: 8     Fields:    Translation:Humans
    117. Dayyani F, Hoffman K, Eifel P, Guo C, Vikram R, Pagliaro LC, Pettaway C. Management of advanced primary urethral carcinomas. BJU Int. 2014 Jul; 114(1):25-31. PMID: 24447439.
      Citations: 25     Fields:    Translation:Humans
    118. Wang J, Kudchadker R, Choi S, Pettaway CA, Choi H, Hobbs BD, Occena MC, McGuire SE, Pugh TJ, Hoffman K, Mahmood U, Kuban DA. Local recurrence map to guide target volume delineation after radical prostatectomy. Pract Radiat Oncol. 2014 Nov-Dec; 4(6):e239-46. PMID: 25407875.
      Citations: 8     Fields:    Translation:Humans
    119. McFall SL, Mullen PD, Byrd TL, Cantor SB, Le YC, Torres-Vigil I, Pettaway C, Volk RJ. Treatment decisions for localized prostate cancer: a concept mapping approach. Health Expect. 2015 Dec; 18(6):2079-90. PMID: 24506829; PMCID: PMC4128894.
      Citations: 7     Fields:    Translation:Humans
    120. Liu CT, Monda KL, Taylor KC, Lange L, Demerath EW, Palmas W, Wojczynski MK, Ellis JC, Vitolins MZ, Liu S, Papanicolaou GJ, Irvin MR, Xue L, Griffin PJ, Nalls MA, Adeyemo A, Liu J, Li G, Ruiz-Narvaez EA, Chen WM, Chen F, Henderson BE, Millikan RC, Ambrosone CB, Strom SS, Guo X, Andrews JS, Sun YV, Mosley TH, Yanek LR, Shriner D, Haritunians T, Rotter JI, Speliotes EK, Smith M, Rosenberg L, Mychaleckyj J, Nayak U, Spruill I, Garvey WT, Pettaway C, Nyante S, Bandera EV, Britton AF, Zonderman AB, Rasmussen-Torvik LJ, Chen YD, Ding J, Lohman K, Kritchevsky SB, Zhao W, Peyser PA, Kardia SL, Kabagambe E, Broeckel U, Chen G, Zhou J, Wassertheil-Smoller S, Neuhouser ML, Rampersaud E, Psaty B, Kooperberg C, Manson JE, Kuller LH, Ochs-Balcom HM, Johnson KC, Sucheston L, Ordovas JM, Palmer JR, Haiman CA, McKnight B, Howard BV, Becker DM, Bielak LF, Liu Y, Allison MA, Grant SF, Burke GL, Patel SR, Schreiner PJ, Borecki IB, Evans MK, Taylor H, Sale MM, Howard V, Carlson CS, Rotimi CN, Cushman M, Harris TB, Reiner AP, Cupples LA, North KE, Fox CS. Genome-wide association of body fat distribution in African ancestry populations suggests new loci. PLoS Genet. 2013; 9(8):e1003681. PMID: 23966867; PMCID: PMC3744443.
      Citations: 62     Fields:    Translation:Humans
    121. Ratcliff CG, Cohen L, Pettaway CA, Parker PA. Treatment regret and quality of life following radical prostatectomy. Support Care Cancer. 2013 Dec; 21(12):3337-43. PMID: 23907238; PMCID: PMC3823814.
      Citations: 12     Fields:    Translation:Humans
    122. Monda KL, Chen GK, Taylor KC, Palmer C, Edwards TL, Lange LA, Ng MC, Adeyemo AA, Allison MA, Bielak LF, Chen G, Graff M, Irvin MR, Rhie SK, Li G, Liu Y, Liu Y, Lu Y, Nalls MA, Sun YV, Wojczynski MK, Yanek LR, Aldrich MC, Ademola A, Amos CI, Bandera EV, Bock CH, Britton A, Broeckel U, Cai Q, Caporaso NE, Carlson CS, Carpten J, Casey G, Chen WM, Chen F, Chen YD, Chiang CW, Coetzee GA, Demerath E, Deming-Halverson SL, Driver RW, Dubbert P, Feitosa MF, Feng Y, Freedman BI, Gillanders EM, Gottesman O, Guo X, Haritunians T, Harris T, Harris CC, Hennis AJ, Hernandez DG, McNeill LH, Howard TD, Howard BV, Howard VJ, Johnson KC, Kang SJ, Keating BJ, Kolb S, Kuller LH, Kutlar A, Langefeld CD, Lettre G, Lohman K, Lotay V, Lyon H, Manson JE, Maixner W, Meng YA, Monroe KR, Morhason-Bello I, Murphy AB, Mychaleckyj JC, Nadukuru R, Nathanson KL, Nayak U, N'diaye A, Nemesure B, Wu SY, Leske MC, Neslund-Dudas C, Neuhouser M, Nyante S, Ochs-Balcom H, Ogunniyi A, Ogundiran TO, Ojengbede O, Olopade OI, Palmer JR, Ruiz-Narvaez EA, Palmer ND, Press MF, Rampersaud E, Rasmussen-Torvik LJ, Rodriguez-Gil JL, Salako B, Schadt EE, Schwartz AG, Shriner DA, Siscovick D, Smith SB, Wassertheil-Smoller S, Speliotes EK, Spitz MR, Sucheston L, Taylor H, Tayo BO, Tucker MA, Van Den Berg DJ, Edwards DR, Wang Z, Wiencke JK, Winkler TW, Witte JS, Wrensch M, Wu X, Yang JJ, Levin AM, Young TR, Zakai NA, Cushman M, Zanetti KA, Zhao JH, Zhao W, Zheng Y, Zhou J, Ziegler RG, Zmuda JM, Fernandes JK, Gilkeson GS, Kamen DL, Hunt KJ, Spruill IJ, Ambrosone CB, Ambs S, Arnett DK, Atwood L, Becker DM, Berndt SI, Bernstein L, Blot WJ, Borecki IB, Bottinger EP, Bowden DW, Burke G, Chanock SJ, Cooper RS, Ding J, Duggan D, Evans MK, Fox C, Garvey WT, Bradfield JP, Hakonarson H, Grant SF, Hsing A, Chu L, Hu JJ, Huo D, Ingles SA, John EM, Jordan JM, Kabagambe EK, Kardia SL, Kittles RA, Goodman PJ, Klein EA, Kolonel LN, Le Marchand L, Liu S, McKnight B, Millikan RC, Mosley TH, Padhukasahasram B, Williams LK, Patel SR, Peters U, Pettaway CA, Peyser PA, Psaty BM, Redline S, Rotimi CN, Rybicki BA, Schreiner PJ, Signorello LB, Singleton AB, Stanford JL, Strom SS, Thun MJ, Vitolins M, Zheng W, Moore JH, Williams SM, Ketkar S, Zhu X, Zonderman AB, NABEC Consortium, UKBEC Consortium, BioBank Japan Project, AGEN Consortium, Kooperberg C, Papanicolaou GJ, Henderson BE, Reiner AP, Hirschhorn JN, Loos RJ, North KE, Haiman CA, Sale MM. A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet. 2013 Jun; 45(6):690-6. PMID: 23583978; PMCID: PMC3694490.
      Citations: 140     Fields:    Translation:Humans
    123. Matin SF, Cormier JN, Ward JF, Pisters LL, Wood CG, Dinney CP, Royal RE, Huang X, Pettaway CA. Phase 1 prospective evaluation of the oncological adequacy of robotic assisted video-endoscopic inguinal lymphadenectomy in patients with penile carcinoma. BJU Int. 2013 Jun; 111(7):1068-74. PMID: 23551693; PMCID: PMC3651805.
      Citations: 22     Fields:    Translation:HumansCTClinical Trials
    124. Ortiz AP, Soto-Salgado M, Pettaway CA, Col?n-L?pez V, Torres-Cintr?n M, Puras-B?ez A, Mart?nez-Ferrer M, Su?rez E. Penile cancer disparities in Puerto Rican men as compared to the United States population. Int Braz J Urol. 2012 Nov-Dec; 38(6):728-38. PMID: 23302411; PMCID: PMC3703478.
      Citations: 8     Fields:    Translation:Humans
    125. Pettaway CA, Crook J, Hegarty PK, Pagliaro L. Penile cancer update 2011: a case-based approach. Urol Oncol. 2012 Nov-Dec; 30(6):956-8. PMID: 23218076.
      Citations:    Fields:    Translation:Humans
    126. Gilts CD, Parker PA, Pettaway CA, Cohen L. Psychosocial moderators of presurgical stress management for men undergoing radical prostatectomy. Health Psychol. 2013 Dec; 32(12):1218-26. PMID: 23088178; PMCID: PMC3833972.
      Citations: 5     Fields:    Translation:Humans
    127. Soto-Salgado M, Pettaway CA, Ortiz AP, Su?rez E, Torres-Cintr?n M, Col?n V. Prostate cancer incidence and mortality among Puerto Ricans: an updated analysis comparing men in Puerto Rico with US racial/ethnic groups. P R Health Sci J. 2012 Sep; 31(3):107-13. PMID: 23038882.
      Citations: 11     Fields:    Translation:Humans
    128. Efstathiou E, Karlou M, Wen S, Hoang A, Pettaway CA, Pisters LL, Maity S, Troncoso P, Logothetis CJ. Integrated Hedgehog signaling is induced following castration in human and murine prostate cancers. Prostate. 2013 Jan; 73(2):153-61. PMID: 22753310; PMCID: PMC3878994.
      Citations: 12     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    129. Dayyani F, Pettaway CA, Kamat AM, Munsell MF, Sircar K, Pagliaro LC. Retrospective analysis of survival outcomes and the role of cisplatin-based chemotherapy in patients with urethral carcinomas referred to medical oncologists. Urol Oncol. 2013 Oct; 31(7):1171-7. PMID: 22534087; PMCID: PMC4131852.
      Citations: 15     Fields:    Translation:Humans
    130. Pisters PW, Pettaway CA, Liu P, Matin SF, Ward JF, Leibovici D. Is transureteroureterostomy performed during multi-organ resection for non-urothelial malignancy safe and effective? J Surg Oncol. 2012 Jul 01; 106(1):62-5. PMID: 22259198.
      Citations: 2     Fields:    Translation:Humans
    131. Shih YC, Ward JF, Pettaway CA, Xu Y, Matin SF, Davis JW, Thompson BP, Elting LS. Comparative effectiveness, cost, and utilization of radical prostatectomy among young men within managed care insurance plans. Value Health. 2012 Mar-Apr; 15(2):367-75. PMID: 22433769.
      Citations: 4     Fields:    Translation:Humans
    132. Chen GK, Palmer CD, Ge B, Tayo B, Mathias RA, Ding J, Nalls MA, Adeyemo A, Ambrosone CB, Atwood L, Bandera EV, Becker LC, Berndt SI, Bernstein L, Blot WJ, Boerwinkle E, Britton A, Casey G, Chanock SJ, Demerath E, Deming SL, Diver WR, Fox C, Harris TB, Hernandez DG, Hu JJ, Ingles SA, John EM, Johnson C, Keating B, Kittles RA, Kolonel LN, Kritchevsky SB, Le Marchand L, Lohman K, Liu J, Millikan RC, Murphy A, Musani S, Neslund-Dudas C, North KE, Nyante S, Ogunniyi A, Ostrander EA, Papanicolaou G, Patel S, Pettaway CA, Press MF, Redline S, Rodriguez-Gil JL, Rotimi C, Rybicki BA, Salako B, Schreiner PJ, Signorello LB, Singleton AB, Stanford JL, Stram AH, Stram DO, Strom SS, Suktitipat B, Thun MJ, Witte JS, Yanek LR, Ziegler RG, Zheng W, Zhu X, Zmuda JM, Zonderman AB, Evans MK, Liu Y, Becker DM, Cooper RS, Pastinen T, Henderson BE, Hirschhorn JN, Lettre G, Haiman CA, N'Diaye A, Adoue V. Identification, replication, and fine-mapping of Loci associated with adult height in individuals of african ancestry. PLoS Genet. 2011 Oct; 7(10):e1002298. PMID: 21998595; PMCID: PMC3188544.
      Citations: 60     Fields:    Translation:Humans
    133. Crawford ED, Moul JW, Rove KO, Pettaway CA, Lamerato LE, Hughes A. Prostate-specific antigen 1.5-4.0 ng/mL: a diagnostic challenge and danger zone. BJU Int. 2011 Dec; 108(11):1743-9. PMID: 21711431.
      Citations: 7     Fields:    Translation:Humans
    134. Marberger M, Freedland SJ, Andriole GL, Emberton M, Pettaway C, Montorsi F, Teloken C, Rittmaster RS, Somerville MC, Castro R. Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE study. BJU Int. 2012 Apr; 109(8):1162-9. PMID: 21699645.
      Citations: 14     Fields:    Translation:Humans
    135. Tzelepi V, Efstathiou E, Wen S, Troncoso P, Karlou M, Pettaway CA, Pisters LL, Hoang A, Logothetis CJ, Pagliaro LC. Persistent, biologically meaningful prostate cancer after 1 year of androgen ablation and docetaxel treatment. J Clin Oncol. 2011 Jun 20; 29(18):2574-81. PMID: 21606419; PMCID: PMC3138635.
      Citations: 26     Fields:    Translation:HumansCellsCTClinical Trials
    136. Hegarty PK, Suh J, Fisher MB, Taylor J, Nguyen TH, Ivan D, Prieto VG, Pagliaro LC, Pettaway CA. Penoscrotal extramammary Paget's disease: the University of Texas M. D. Anderson Cancer Center contemporary experience. J Urol. 2011 Jul; 186(1):97-102. PMID: 21571343.
      Citations: 13     Fields:    Translation:Humans
    137. del Junco DJ, Fox EE, Cooper S, Goldhagen M, Koda E, Rogers D, Canby-Hagino E, Kim J, Pettaway C, Boyd DD. Increasing low risk prostate cancer incidence in United States Air Force servicemen and selection of treatments. J Urol. 2011 Jun; 185(6):2137-42. PMID: 21496842; PMCID: PMC3171171.
      Citations:    Fields:    Translation:Humans
    138. Pettaway CA, Lamerato LE, Eaddy MT, Edwards JK, Hogue SL, Crane MM. Benign prostatic hyperplasia: racial differences in treatment patterns and prostate cancer prevalence. BJU Int. 2011 Oct; 108(8):1302-8. PMID: 21371244.
      Citations: 4     Fields:    Translation:Humans
    139. Cohen L, Parker PA, Vence L, Savary C, Kentor D, Pettaway C, Babaian R, Pisters L, Miles B, Wei Q, Wiltz L, Patel T, Radvanyi L. Presurgical stress management improves postoperative immune function in men with prostate cancer undergoing radical prostatectomy. Psychosom Med. 2011 Apr; 73(3):218-25. PMID: 21257977.
      Citations: 17     Fields:    Translation:HumansCells
    140. Delacroix SE, Pettaway CA. Therapeutic strategies for advanced penile carcinoma. Curr Opin Support Palliat Care. 2010 Dec; 4(4):285-92. PMID: 20844435.
      Citations: 2     Fields:    Translation:Humans
    141. Andriole GL, Bostwick D, Brawley OW, Gomella L, Marberger M, Montorsi F, Pettaway C, Tammela TL, Teloken C, Tindall D, Freedland SJ, Somerville MC, Wilson TH, Fowler I, Castro R, Rittmaster RS, REDUCE Study Group. The effect of dutasteride on the usefulness of prostate specific antigen for the diagnosis of high grade and clinically relevant prostate cancer in men with a previous negative biopsy: results from the REDUCE study. J Urol. 2011 Jan; 185(1):126-31. PMID: 21074214.
      Citations: 27     Fields:    Translation:Humans
    142. Gorlov IP, Sircar K, Zhao H, Maity SN, Navone NM, Gorlova OY, Troncoso P, Pettaway CA, Byun JY, Logothetis CJ. Prioritizing genes associated with prostate cancer development. BMC Cancer. 2010 Nov 02; 10:599. PMID: 21044312; PMCID: PMC2988752.
      Citations: 19     Fields:    Translation:Humans
    143. Pettaway CA. Editorial comment. Urology. 2010 Sep; 76(3):564; discussion 564-5. PMID: 20832603.
      Citations:    Fields:    
    144. Hegarty PK, Dinney CP, Pettaway CA. Controversies in ilioinguinal lymphadenectomy. Urol Clin North Am. 2010 Aug; 37(3):421-34. PMID: 20674697.
      Citations: 5     Fields:    Translation:Humans
    145. Pettaway CA, Pagliaro L, Theodore C, Haas G. Treatment of visceral, unresectable, or bulky/unresectable regional metastases of penile cancer. Urology. 2010 Aug; 76(2 Suppl 1):S58-65. PMID: 20691886.
      Citations: 13     Fields:    Translation:Humans
    146. Pagliaro LC, Williams DL, Daliani D, Williams MB, Osai W, Kincaid M, Wen S, Thall PF, Pettaway CA. Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J Clin Oncol. 2010 Aug 20; 28(24):3851-7. PMID: 20625118; PMCID: PMC2940402.
      Citations: 79     Fields:    Translation:HumansCTClinical Trials
    147. Velazquez EF, Amin MB, Epstein JI, Grignon DJ, Humphrey PA, Pettaway CA, Renshaw AA, Reuter VE, Srigley JR, Cubilla AL, Members of the Cancer Committee, College of American Pathologists. Protocol for the examination of specimens from patients with carcinoma of the penis. Arch Pathol Lab Med. 2010 Jun; 134(6):923-9. PMID: 20524869.
      Citations:    Fields:    Translation:Humans
    148. Sterba KR, Swartz RJ, Basen-Engquist K, Black PC, Pettaway CA. Long-term quality of life after radical prostatectomy in wives of men in the postoperative adjuvant androgen deprivation trial. Support Care Cancer. 2011 Aug; 19(8):1117-24. PMID: 20499107; PMCID: PMC3546513.
      Citations: 4     Fields:    Translation:Humans
    149. Song R, Harris LD, Pettaway CA. Downmodulation of Bcl-2 sensitizes metastatic LNCaP-LN3 cells to undergo apoptosis via the intrinsic pathway. Prostate. 2010 May 01; 70(6):571-83. PMID: 19938012.
      Citations: 6     Fields:    Translation:HumansCells
    150. Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, Pettaway CA, Tammela TL, Teloken C, Tindall DJ, Somerville MC, Wilson TH, Fowler IL, Rittmaster RS, REDUCE Study Group. Effect of dutasteride on the risk of prostate cancer. N Engl J Med. 2010 Apr 01; 362(13):1192-202. PMID: 20357281.
      Citations: 344     Fields:    Translation:Humans
    151. Zafirakis H, De EJ, Pisters LL, Pettaway C, Westney OL. Long-term outcomes and patient satisfaction of continent catheterizable limb and augmentation cystoplasty simultaneous with salvage prostatectomy. Neurourol Urodyn. 2010; 29 Suppl 1:S51-6. PMID: 20419802.
      Citations:    Fields:    Translation:Humans
    152. Pettaway CA. Editorial comment: The management debate continues! Can J Urol. 2009 Dec; 16(6):4899-900; discussion 4900. PMID: 20003663.
      Citations:    Fields:    Translation:Humans
    153. Davis JW, Kamat A, Munsell M, Pettaway C, Pisters L, Matin S. Initial experience of teaching robot-assisted radical prostatectomy to surgeons-in-training: can training be evaluated and standardized? BJU Int. 2010 Apr; 105(8):1148-54. PMID: 19874300.
      Citations: 12     Fields:    Translation:Humans
    154. Efstathiou E, Abrahams NA, Tibbs RF, Wang X, Pettaway CA, Pisters LL, Mathew PF, Do KA, Logothetis CJ, Troncoso P. Morphologic characterization of preoperatively treated prostate cancer: toward a post-therapy histologic classification. Eur Urol. 2010 Jun; 57(6):1030-8. PMID: 19853370; PMCID: PMC2962710.
      Citations: 20     Fields:    Translation:Humans
    155. Svatek RS, Munsell M, Kincaid JM, Hegarty P, Slaton JW, Busby JE, Gaston KE, Spiess PE, Pagliaro LC, Tamboli P, Pettaway CA. Association between lymph node density and disease specific survival in patients with penile cancer. J Urol. 2009 Dec; 182(6):2721-7. PMID: 19837433.
      Citations: 15     Fields:    Translation:Humans
    156. Parker PA, Pettaway CA, Babaian RJ, Pisters LL, Miles B, Fortier A, Wei Q, Carr DD, Cohen L. The effects of a presurgical stress management intervention for men with prostate cancer undergoing radical prostatectomy. J Clin Oncol. 2009 Jul 01; 27(19):3169-76. PMID: 19349551; PMCID: PMC2716938.
      Citations: 18     Fields:    Translation:Humans
    157. Pettaway CA, Horenblas S. Penile cancer: incremental insights into etiology, diagnosis, staging, and management. World J Urol. 2009 Apr; 27(2):139-40. PMID: 19142645.
      Citations: 1     Fields:    Translation:Humans
    158. Tsavachidou D, McDonnell TJ, Wen S, Wang X, Vakar-Lopez F, Pisters LL, Pettaway CA, Wood CG, Do KA, Thall PF, Stephens C, Efstathiou E, Taylor R, Menter DG, Troncoso P, Lippman SM, Logothetis CJ, Kim J. Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 04; 101(5):306-20. PMID: 19244175; PMCID: PMC2734116.
      Citations: 26     Fields:    Translation:HumansCTClinical Trials
    159. Chen H, Liakou CI, Kamat A, Pettaway C, Ward JF, Tang DN, Sun J, Jungbluth AA, Troncoso P, Logothetis C, Sharma P. Anti-CTLA-4 therapy results in higher CD4+ICOShi T cell frequency and IFN-gamma levels in both nonmalignant and malignant prostate tissues. Proc Natl Acad Sci U S A. 2009 Feb 24; 106(8):2729-34. PMID: 19202079; PMCID: PMC2650334.
      Citations: 99     Fields:    Translation:HumansCells
    160. Robbins CM, Hernandez W, Ahaghotu C, Bennett J, Hoke G, Mason T, Pettaway CA, Vijayakumar S, Weinrich S, Furbert-Harris P, Dunston G, Powell IJ, Carpten JD, Kittles RA. Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases. Prostate. 2008 Dec 01; 68(16):1790-7. PMID: 18767027; PMCID: PMC4097307.
      Citations: 23     Fields:    Translation:Humans
    161. Mathew P, Pisters LL, Wood CG, Papadopoulos JN, Williams DL, Thall PF, Wen S, Horne E, Oborn CJ, Langley R, Fidler IJ, Pettaway CA. Neoadjuvant platelet derived growth factor receptor inhibitor therapy combined with docetaxel and androgen ablation for high risk localized prostate cancer. J Urol. 2009 Jan; 181(1):81-7; discussion 87. PMID: 19012911.
      Citations: 13     Fields:    Translation:Humans
    162. Pettaway CA, Song R, Wang X, Sanchez-Ortiz R, Spiess PE, Strom S, Troncoso P. The ratio of matrix metalloproteinase to E-cadherin expression: a pilot study to assess mRNA and protein expression among African American prostate cancer patients. Prostate. 2008 Sep 15; 68(13):1467-76. PMID: 18618693; PMCID: PMC2574568.
      Citations: 4     Fields:    Translation:Humans
    163. Davis JW, Chang DW, Chevray P, Wang R, Shen Y, Wen S, Pettaway CA, Pisters LL, Swanson DA, Madsen LT, Huber N, Troncoso P, Babaian RJ, Wood CG. Randomized phase II trial evaluation of erectile function after attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancer. Eur Urol. 2009 May; 55(5):1135-43. PMID: 18783876; PMCID: PMC10651170.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    164. Spiess PE, Hernandez MS, Pettaway CA. Contemporary inguinal lymph node dissection: minimizing complications. World J Urol. 2009 Apr; 27(2):205-12. PMID: 18762945.
      Citations: 28     Fields:    Translation:Humans
    165. Strom SS, Yamamura Y, Forman MR, Pettaway CA, Barrera SL, DiGiovanni J. Saturated fat intake predicts biochemical failure after prostatectomy. Int J Cancer. 2008 Jun 01; 122(11):2581-5. PMID: 18324626.
      Citations: 27     Fields:    Translation:Humans
    166. Strom SS, Yamamura Y, Flores-Sandoval FN, Pettaway CA, Lopez DS. Prostate cancer in Mexican-Americans: identification of risk factors. Prostate. 2008 Apr 01; 68(5):563-70. PMID: 18247399.
      Citations: 12     Fields:    Translation:HumansPHPublic Health
    167. Cooksley C, Kamat AM, Pettaway CA, Elting LS, C?rdenas-Turanzas M. Gender and age differences in blood utilization and length of stay in radical cystectomy: a population-based study. Int Urol Nephrol. 2008; 40(4):893-9. PMID: 18317944.
      Citations: 8     Fields:    Translation:Humans
    168. Cooksley CD, Avritscher EB, Grossman HB, Sabichi AL, Dinney CP, Pettaway C, Elting LS. Clinical model of cost of bladder cancer in the elderly. Urology. 2008 Mar; 71(3):519-25. PMID: 18342201.
      Citations: 15     Fields:    Translation:Humans
    169. Spiess PE, Pisters LL, Liu P, Pettaway CA, Kamat AM, Gomez JA, Tannir NM. Malignant transformation of testicular teratoma: a chemoresistant phenotype. Urol Oncol. 2008 Nov-Dec; 26(6):595-9. PMID: 18367105; PMCID: PMC4121060.
      Citations: 10     Fields:    Translation:Humans
    170. Spiess PE, Pettaway CA, Vakar-Lopez F, Kassouf W, Wang X, Busby JE, Do KA, Davuluri R, Tannir NM. Treatment outcomes of small cell carcinoma of the prostate: a single-center study. Cancer. 2007 Oct 15; 110(8):1729-37. PMID: 17786954.
      Citations: 40     Fields:    Translation:HumansCTClinical Trials
    171. Leibovici D, Kassouf W, Pisters LL, Pettaway CA, Wu X, Dinney CP, Grossman HB. Organ preservation for muscle-invasive bladder cancer by transurethral resection. Urology. 2007 Sep; 70(3):473-6. PMID: 17905099.
      Citations: 10     Fields:    Translation:Humans
    172. Brown GA, Matin SF, Busby JE, Dinney CP, Grossman HB, Pettaway CA, Munsell MF, Kamat AM. Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy. Urology. 2007 Aug; 70(2):252-6. PMID: 17826484; PMCID: PMC2034451.
      Citations: 27     Fields:    Translation:Humans
    173. Weinrich S, Vijayakumar S, Powell IJ, Priest J, Hamner CA, McCloud L, Pettaway C. Knowledge of hereditary prostate cancer among high-risk African American men. Oncol Nurs Forum. 2007 Jul; 34(4):854-60. PMID: 17723986.
      Citations: 4     Fields:    Translation:Humans
    174. Black PC, Basen-Engquist K, Wang X, Swartz RJ, Eddings T, Matin SF, Swanson D, Wood CG, Pisters LL, Babaian RJ, Troncoso P, Pettaway CA. A randomized prospective trial evaluating testosterone, haemoglobin kinetics and quality of life, during and after 12 months of androgen deprivation after prostatectomy: results from the Postoperative Adjuvant Androgen Deprivation trial. BJU Int. 2007 Jul; 100(1):63-9. PMID: 17552954.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    175. Spiess PE, Izawa JI, Bassett R, Kedar D, Busby JE, Wong F, Eddings T, Tamboli P, Pettaway CA. Preoperative lymphoscintigraphy and dynamic sentinel node biopsy for staging penile cancer: results with pathological correlation. J Urol. 2007 Jun; 177(6):2157-61. PMID: 17509308.
      Citations: 20     Fields:    Translation:Humans
    176. De E, Pisters LL, Pettaway CA, Scott S, Westney OL. Salvage prostatectomy with bladder neck closure, continent catheterizable stoma and bladder augmentation: feasibility and patient reported continence outcomes at 32 months. J Urol. 2007 Jun; 177(6):2200-4; discussion 2204. PMID: 17509319.
      Citations: 1     Fields:    Translation:Humans
    177. Bermejo C, Busby JE, Spiess PE, Heller L, Pagliaro LC, Pettaway CA. Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol. 2007 Apr; 177(4):1335-8. PMID: 17382727.
      Citations: 40     Fields:    Translation:Humans
    178. Efstathiou E, Troncoso P, Wen S, Do KA, Pettaway CA, Pisters LL, McDonnell TJ, Logothetis CJ. Initial modulation of the tumor microenvironment accounts for thalidomide activity in prostate cancer. Clin Cancer Res. 2007 Feb 15; 13(4):1224-31. PMID: 17317833.
      Citations: 24     Fields:    Translation:HumansCellsCTClinical Trials
    179. Carmack Taylor CL, de Moor C, Basen-Engquist K, Smith MA, Dunn AL, Badr H, Pettaway C, Gritz ER. Moderator analyses of participants in the Active for Life after cancer trial: implications for physical activity group intervention studies. Ann Behav Med. 2007 Feb; 33(1):99-104. PMID: 17291175.
      Citations: 16     Fields:    Translation:Humans
    180. Leibovici D, Spiess PE, Agarwal PK, Tu SM, Pettaway CA, Hitzhusen K, Millikan RE, Pisters LL. Prostate cancer progression in the presence of undetectable or low serum prostate-specific antigen level. Cancer. 2007 Jan 15; 109(2):198-204. PMID: 17171704.
      Citations: 30     Fields:    Translation:Humans
    181. Baffoe-Bonnie AB, Kittles RA, Gillanders E, Ou L, George A, Robbins C, Ahaghotu C, Bennett J, Boykin W, Hoke G, Mason T, Pettaway C, Vijayakumar S, Weinrich S, Jones MP, Gildea D, Riedesel E, Albertus J, Moses T, Lockwood E, Klaric M, Faruque M, Royal C, Trent JM, Berg K, Collins FS, Furbert-Harris PM, Bailey-Wilson JE, Dunston GM, Powell I, Carpten JD. Genome-wide linkage of 77 families from the African American Hereditary Prostate Cancer study (AAHPC). Prostate. 2007 Jan 01; 67(1):22-31. PMID: 17031815.
      Citations: 13     Fields:    Translation:Humans
    182. Brown GA, Busby JE, Wood CG, Pisters LL, Dinney CP, Swanson DA, Grossman HB, Pettaway CA, Munsell MF, Kamat AM, Matin SF. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm? BJU Int. 2006 Dec; 98(6):1176-80. PMID: 17125474.
      Citations: 30     Fields:    Translation:Humans
    183. Carmack Taylor CL, Demoor C, Smith MA, Dunn AL, Basen-Engquist K, Nielsen I, Pettaway C, Sellin R, Massey P, Gritz ER. Active for Life After Cancer: a randomized trial examining a lifestyle physical activity program for prostate cancer patients. Psychooncology. 2006 Oct; 15(10):847-62. PMID: 16447306.
      Citations: 47     Fields:    Translation:Humans
    184. Evans JG, Spiess PE, Kamat AM, Wood CG, Hernandez M, Pettaway CA, Dinney CP, Pisters LL. Chylous ascites after post-chemotherapy retroperitoneal lymph node dissection: review of the M. D. Anderson experience. J Urol. 2006 Oct; 176(4 Pt 1):1463-7. PMID: 16952661.
      Citations: 27     Fields:    Translation:Humans
    185. Cooksley C, Pettaway CA, Sabichi A, Grossman HB, Elting L, C?rdenas-Turanzas M. Comparative outcomes of bladder cancer. Obstet Gynecol. 2006 Jul; 108(1):169-75. PMID: 16816072.
      Citations: 6     Fields:    Translation:Humans
    186. Sanchez-Ortiz RF, Troncoso P, Babaian RJ, Lloreta J, Johnston DA, Pettaway CA. African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men. Cancer. 2006 Jul 01; 107(1):75-82. PMID: 16736511.
      Citations: 44     Fields:    Translation:Humans
    187. Anai S, Pendleton J, Wludyka P, Williams C, Nelms L, Pettaway C, Rosser CJ. Prostate cancer screening and detection in inner-city and underserved men. J Natl Med Assoc. 2006 Apr; 98(4):515-9. PMID: 16623063; PMCID: PMC2569232.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    188. Bielenberg DR, Pettaway CA, Takashima S, Klagsbrun M. Neuropilins in neoplasms: expression, regulation, and function. Exp Cell Res. 2006 Mar 10; 312(5):584-93. PMID: 16445911.
      Citations: 108     Fields:    Translation:HumansAnimalsCells
    189. Leibovici D, Kamat AM, Pettaway CA, Pagliaro L, Rosser CJ, Logothetis C, Pisters LL. Cystoprostatectomy for effective palliation of symptomatic bladder invasion by prostate cancer. J Urol. 2005 Dec; 174(6):2186-90. PMID: 16280761.
      Citations: 13     Fields:    Translation:Humans
    190. Strom SS, Wang X, Pettaway CA, Logothetis CJ, Yamamura Y, Do KA, Babaian RJ, Troncoso P. Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy. Clin Cancer Res. 2005 Oct 01; 11(19 Pt 1):6889-94. PMID: 16203779.
      Citations: 34     Fields:    Translation:Humans
    191. Kittles RA, Baffoe-Bonnie AB, Moses TY, Robbins CM, Ahaghotu C, Huusko P, Pettaway C, Vijayakumar S, Bennett J, Hoke G, Mason T, Weinrich S, Trent JM, Collins FS, Mousses S, Bailey-Wilson J, Furbert-Harris P, Dunston G, Powell IJ, Carpten JD. A common nonsense mutation in EphB2 is associated with prostate cancer risk in African American men with a positive family history. J Med Genet. 2006 Jun; 43(6):507-11. PMID: 16155194; PMCID: PMC2564535.
      Citations: 33     Fields:    Translation:Humans
    192. Elting LS, Pettaway C, Bekele BN, Grossman HB, Cooksley C, Avritscher EB, Saldin K, Dinney CP. Correlation between annual volume of cystectomy, professional staffing, and outcomes: a statewide, population-based study. Cancer. 2005 Sep 01; 104(5):975-84. PMID: 16044400.
      Citations: 35     Fields:    Translation:Humans
    193. Busby JE, Pettaway CA. What's new in the management of penile cancer? Curr Opin Urol. 2005 Sep; 15(5):350-7. PMID: 16093861.
      Citations: 4     Fields:    Translation:Humans
    194. Kim J, Sun P, Lam YW, Troncoso P, Sabichi AL, Babaian RJ, Pisters LL, Pettaway CA, Wood CG, Lippman SM, McDonnell TJ, Lieberman R, Logothetis C, Ho SM. Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancer. Cancer Epidemiol Biomarkers Prev. 2005 Jul; 14(7):1697-702. PMID: 16030104.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    195. Uehara H, Troncoso P, Johnston D, Bucana CD, Dinney C, Dong Z, Fidler IJ, Pettaway CA. Expression of interleukin-8 gene in radical prostatectomy specimens is associated with advanced pathologic stage. Prostate. 2005 Jun 15; 64(1):40-9. PMID: 15651067.
      Citations: 32     Fields:    Translation:Humans
    196. Zhang F, Lee J, Lu S, Pettaway CA, Dong Z. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice. Clin Cancer Res. 2005 Jun 15; 11(12):4512-20. PMID: 15958637.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    197. Huang SF, Tamboli P, Prieto VG, Hester G, Pettaway CA, S?nchez-Ortiz R. Melanoma of the penis, scrotum and male urethra: a 40-year single institution experience. J Urol. 2005 Jun; 173(6):1958-65. PMID: 15879790.
      Citations: 17     Fields:    Translation:Humans
    198. Izawa J, Kedar D, Wong F, Pettaway CA. Sentinel lymph node biopsy in penile cancer: evolution and insights. Can J Urol. 2005 Feb; 12 Suppl 1:24-9. PMID: 15780161.
      Citations: 3     Fields:    Translation:Humans
    199. Leibovici D, Kamat AM, Do KA, Pettaway CA, Ng CS, Evans RB, Rodriguez-Bigas M, Skibber J, Wang X, Pisters LL. Transrectal ultrasound versus magnetic resonance imaging for detection of rectal wall invasion by prostate cancer. Prostate. 2005 Jan 01; 62(1):101-4. PMID: 15389800.
      Citations: 6     Fields:    Translation:Humans
    200. Wyatt RB, Wood CG, Ramirez E, Logothetis C, Pettaway CA, S?nchez-Ortiz RF. Prognostic factors for survival among Caucasian, African-American and Hispanic men with androgen-independent prostate cancer. J Natl Med Assoc. 2004 Dec; 96(12):1587-93. PMID: 15622688; PMCID: PMC2568655.
      Citations: 6     Fields:    Translation:Humans
    201. Strom SS, Gu Y, Zhang H, Troncoso P, Babaian RJ, Pettaway CA, Shete S, Spitz MR, Logothetis CJ. Androgen receptor polymorphisms and risk of biochemical failure among prostatectomy patients. Prostate. 2004 Sep 01; 60(4):343-51. PMID: 15264247.
      Citations: 8     Fields:    Translation:HumansCells
    202. Rosser CJ, Kuban DA, Lee SJ, Levy LB, Pettaway C, Kamat AM, Chichakli R, Lee A, Cheung RM, Sanchez-Ortiz R, Pisters LL. Racial influence on biochemical disease-free survival in men treated with external-beam radiotherapy for localized prostate cancer. J Natl Med Assoc. 2004 Jul; 96(7):939-44. PMID: 15253325; PMCID: PMC2568437.
      Citations: 7     Fields:    Translation:Humans
    203. Nakamori M, Fu X, Pettaway CA, Zhang X. Potent antitumor activity after systemic delivery of a doubly fusogenic oncolytic herpes simplex virus against metastatic prostate cancer. Prostate. 2004 Jun 15; 60(1):53-60. PMID: 15129429.
      Citations: 17     Fields:    Translation:HumansAnimalsCells
    204. Carmack Taylor CL, Smith MA, de Moor C, Dunn AL, Pettaway C, Sellin R, Charnsangavej C, Hansen MC, Gritz ER. Quality of life intervention for prostate cancer patients: design and baseline characteristics of the active for life after cancer trial. Control Clin Trials. 2004 Jun; 25(3):265-85. PMID: 15157729.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    205. Hall CL, Tsan R, Mugnai G, Mazar A, Radinsky R, Pettaway CA. Enhanced invasion of hormone refractory prostate cancer cells through hepatocyte growth factor (HGF) induction of urokinase-type plasminogen activator (u-PA). Prostate. 2004 May 01; 59(2):167-76. PMID: 15042617.
      Citations: 4     Fields:    Translation:HumansCells
    206. Kamat AM, Plager C, Tamboli P, Tran N, Pettaway CA. Metastatic epithelioid hemangioendothelioma of the penis managed with surgery and interferon-alpha. J Urol. 2004 May; 171(5):1886-7. PMID: 15076299.
      Citations: 3     Fields:    Translation:Humans
    207. Pettaway CA, S?nchez-Ortiz RF. The role of lymphadenectomy in penile cancer. Urol Oncol. 2004 May-Jun; 22(3):236-44; discussion 244-5. PMID: 15271324.
      Citations: 14     Fields:    Translation:Humans
    208. Pisters LL, Pettaway CA, Troncoso P, McDonnell TJ, Stephens LC, Wood CG, Do KA, Brisbay SM, Wang X, Hossan EA, Evans RB, Soto C, Jacobson MG, Parker K, Merritt JA, Steiner MS, Logothetis CJ. Evidence that transfer of functional p53 protein results in increased apoptosis in prostate cancer. Clin Cancer Res. 2004 Apr 15; 10(8):2587-93. PMID: 15102659.
      Citations: 14     Fields:    Translation:HumansCells
    209. Ruiz M, Pettaway C, Song R, Stoeltzing O, Ellis L, Bar-Eli M. Activator protein 2alpha inhibits tumorigenicity and represses vascular endothelial growth factor transcription in prostate cancer cells. Cancer Res. 2004 Jan 15; 64(2):631-8. PMID: 14744778.
      Citations: 37     Fields:    Translation:HumansAnimalsCells
    210. Ahaghotu C, Baffoe-Bonnie A, Kittles R, Pettaway C, Powell I, Royal C, Wang H, Vijayakumar S, Bennett J, Hoke G, Mason T, Bailey-Wilson J, Boykin W, Berg K, Carpten J, Weinrich S, Trent J, Dunston G, Collins F. Clinical characteristics of African-American men with hereditary prostate cancer: the AAHPC Study. Prostate Cancer Prostatic Dis. 2004; 7(2):165-9. PMID: 15175665.
      Citations: 7     Fields:    Translation:Humans
    211. Kamat AM, Huang SF, Bermejo CE, Rosser CJ, Pettaway CA, Pisters PW, Guitreau D, Pisters LL. Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer. J Urol. 2003 Nov; 170(5):1868-71. PMID: 14532795.
      Citations: 13     Fields:    Translation:Humans
    212. Rosser CJ, Kuban DA, Levy LB, Pettaway CA, Chichakli R, Kamat AM, Sanchez-Ortiz RF, Pisters LL. Clinical features and treatment outcome of Hispanic men with prostate cancer following external beam radiotherapy. J Urol. 2003 Nov; 170(5):1856-9. PMID: 14532792.
      Citations: 2     Fields:    Translation:Humans
    213. Pettaway CA, S?nchez-Ortiz RF. Natural history, management, and surveillance of recurrent squamous cell penile carcinoma: a risk-based approach. Urol Clin North Am. 2003 Nov; 30(4):853-67. PMID: 14680320.
      Citations: 3     Fields:    Translation:Humans
    214. Williams S, Pettaway C, Song R, Papandreou C, Logothetis C, McConkey DJ. Differential effects of the proteasome inhibitor bortezomib on apoptosis and angiogenesis in human prostate tumor xenografts. Mol Cancer Ther. 2003 Sep; 2(9):835-43. PMID: 14555702.
      Citations: 44     Fields:    Translation:HumansAnimalsCells
    215. Sweeney P, Millikan R, Donat M, Wood CG, Radtke AS, Pettaway CA, Grossman HB, Dinney CP, Swanson DA, Pisters LL. Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder? J Urol. 2003 Jun; 169(6):2113-7. PMID: 12771730.
      Citations: 39     Fields:    Translation:HumansCTClinical Trials
    216. Kuniyasu H, Ukai R, Johnston D, Troncoso P, Fidler IJ, Pettaway CA. The relative mRNA expression levels of matrix metalloproteinase to E-cadherin in prostate biopsy specimens distinguishes organ-confined from advanced prostate cancer at radical prostatectomy. Clin Cancer Res. 2003 Jun; 9(6):2185-94. PMID: 12796385.
      Citations: 7     Fields:    Translation:Humans
    217. Sweeney P, Karashima T, Kim SJ, Kedar D, Mian B, Huang S, Baker C, Fan Z, Hicklin DJ, Pettaway CA, Dinney CP. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production. Clin Cancer Res. 2002 Aug; 8(8):2714-24. PMID: 12171905.
      Citations: 33     Fields:    Translation:HumansAnimalsCells
    218. Tu SM, Reyes A, Maa A, Bhowmick D, Pisters LL, Pettaway CA, Lin SH, Troncoso P, Logothetis CJ. Prostate carcinoma with testicular or penile metastases. Clinical, pathologic, and immunohistochemical features. Cancer. 2002 May 15; 94(10):2610-7. PMID: 12173328.
      Citations: 41     Fields:    Translation:Humans
    219. Karashima T, Sweeney P, Slaton JW, Kim SJ, Kedar D, Izawa JI, Fan Z, Pettaway C, Hicklin DJ, Shuin T, Dinney CP. Inhibition of angiogenesis by the antiepidermal growth factor receptor antibody ImClone C225 in androgen-independent prostate cancer growing orthotopically in nude mice. Clin Cancer Res. 2002 May; 8(5):1253-64. PMID: 12006546.
      Citations: 16     Fields:    Translation:HumansAnimalsCells
    220. Bevan-Thomas R, Slaton JW, Pettaway CA. Contemporary morbidity from lymphadenectomy for penile squamous cell carcinoma: the M.D. Anderson Cancer Center Experience. J Urol. 2002 Apr; 167(4):1638-42. PMID: 11912379.
      Citations: 55     Fields:    Translation:Humans
    221. Weinrich S, Royal C, Pettaway CA, Dunston G, Faison-Smith L, Priest JH, Roberson-Smith P, Frost J, Jenkins J, Brooks KA, Powell I. Interest in genetic prostate cancer susceptibility testing among african American men. Cancer Nurs. 2002 Feb; 25(1):28-34. PMID: 11838717.
      Citations: 9     Fields:    Translation:Humans
    222. Powell IJ, Carpten J, Dunston G, Kittles R, Bennett J, Hoke G, Pettaway C, Weinrich S, Vijayakumar S, Ahaghotu CA, Boykin W, Mason T, Royal C, Baffoe-Bonnie A, Bailey-Wilson J, Berg K, Trent J, Collins F. African-American heredity prostate cancer study: a model for genetic research. J Natl Med Assoc. 2001 Dec; 93(12 Suppl):25S-28S. PMID: 11798061; PMCID: PMC2719991.
      Citations:    Fields:    Translation:Humans
    223. Giesler EJ, Gee JR, Reece GP, Pettaway CA, Pollock RE, Pisters LL. Cutaneous metastases of penile squamous cell carcinoma following en bloc resection of inguinal recurrence with immediate pedicle flap reconstruction. J Urol. 2001 Oct; 166(4):1384-5. PMID: 11547082.
      Citations: 1     Fields:    Translation:Humans
    224. Kuniyasu H, Yasui W, Pettaway CA, Yano S, Oue N, Tahara E, Fidler IJ. Interferon-alpha prevents selection of doxorubicin-resistant undifferentiated-androgen-insensitive metastatic human prostate cancer cells. Prostate. 2001 Sep 15; 49(1):19-29. PMID: 11550207.
      Citations: 11     Fields:    Translation:HumansCells
    225. Huang S, Pettaway CA, Uehara H, Bucana CD, Fidler IJ. Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene. 2001 Jul 12; 20(31):4188-97. PMID: 11464285.
      Citations: 196     Fields:    Translation:HumansAnimalsCells
    226. Chu LW, Pettaway CA, Liang JC. Genetic abnormalities specifically associated with varying metastatic potential of prostate cancer cell lines as detected by comparative genomic hybridization. Cancer Genet Cytogenet. 2001 Jun; 127(2):161-7. PMID: 11425457.
      Citations: 5     Fields:    Translation:HumansCells
    227. Powell IJ, Carpten J, Dunston G, Kittles R, Bennett J, Hoke G, Pettaway C, Weinrich S, Vijayakumar S, Ahaghotu CA, Boykin W, Mason T, Royal C, Baffoe-Bonnie A, Bailey-Wilson J, Berg K, Trent J, Collins F. African-American heredity prostate cancer study: a model for genetic research. J Natl Med Assoc. 2001 Apr; 93(4):120-3. PMID: 12653398; PMCID: PMC2593987.
      Citations: 6     Fields:    Translation:HumansCells
    228. Slaton JW, Morgenstern N, Levy DA, Santos MW, Tamboli P, Ro JY, Ayala AG, Pettaway CA. Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer. J Urol. 2001 Apr; 165(4):1138-42. PMID: 11257655.
      Citations: 50     Fields:    Translation:Humans
    229. Royal C, Baffoe-Bonnie A, Kittles R, Powell I, Bennett J, Hoke G, Pettaway C, Weinrich S, Vijayakumar S, Ahaghotu C, Mason T, Johnson E, Obeikwe M, Simpson C, Mejia R, Boykin W, Roberson P, Frost J, Faison-Smith L, Meegan C, Foster N, Furbert-Harris P, Carpten J, Bailey-Wilson J, Trent J, Berg K, Dunston G, Collins F. Recruitment experience in the first phase of the African American Hereditary Prostate Cancer (AAHPC) study. Ann Epidemiol. 2000 Nov; 10(8 Suppl):S68-77. PMID: 11189095.
      Citations: 40     Fields:    Translation:Humans
    230. Kuniyasu H, Troncoso P, Johnston D, Bucana CD, Tahara E, Fidler IJ, Pettaway CA. Relative expression of type IV collagenase, E-cadherin, and vascular endothelial growth factor/vascular permeability factor in prostatectomy specimens distinguishes organ-confined from pathologically advanced prostate cancers. Clin Cancer Res. 2000 Jun; 6(6):2295-308. PMID: 10873080.
      Citations: 21     Fields:    Translation:Humans
    231. Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, Yano S, Bar-Eli M, Radinsky R, Pettaway CA, Dinney CP. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Clin Cancer Res. 2000 May; 6(5):2104-19. PMID: 10815938.
      Citations: 121     Fields:    Translation:HumansAnimalsCells
    232. Pettaway CA, Pisters LL, Troncoso P, Slaton J, Finn L, Kamoi K, Logothetis CJ. Neoadjuvant chemotherapy and hormonal therapy followed by radical prostatectomy: feasibility and preliminary results. J Clin Oncol. 2000 Mar; 18(5):1050-7. PMID: 10694556.
      Citations: 23     Fields:    Translation:HumansCTClinical Trials
    233. Pettaway CA. Racial differences in the androgen/androgen receptor pathway in prostate cancer. J Natl Med Assoc. 1999 Dec; 91(12):653-60. PMID: 10628124; PMCID: PMC2608588.
      Citations: 14     Fields:    Translation:HumansCells
    234. Pisters LL, Pettaway CA, Hossan E, Evans R, Steiner MS, Wood CG, Troncoso P, McDonnell TJ, Fenstenmacher MJ, Logothetis CJ. Intraprostatic AD-p53 gene therapy followed by radical prostatectomy: feasibility and preliminary results. Prostate Cancer Prostatic Dis. 1999 Nov; 2(S3):S27. PMID: 12496806.
      Citations: 1     Fields:    
    235. Balbay MD, Pettaway CA, Kuniyasu H, Inoue K, Ramirez E, Li E, Fidler IJ, Dinney CP. Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor. Clin Cancer Res. 1999 Apr; 5(4):783-9. PMID: 10213213.
      Citations: 24     Fields:    Translation:HumansAnimalsCells
    236. Dong Z, Greene G, Pettaway C, Dinney CP, Eue I, Lu W, Bucana CD, Balbay MD, Bielenberg D, Fidler IJ. Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta. Cancer Res. 1999 Feb 15; 59(4):872-9. PMID: 10029078.
      Citations: 28     Fields:    Translation:HumansAnimalsCells
    237. Pisters LL, Dinney CP, Pettaway CA, Scott SM, Babaian RJ, von Eschenbach AC, Troncoso P. A feasibility study of cryotherapy followed by radical prostatectomy for locally advanced prostate cancer. J Urol. 1999 Feb; 161(2):509-14. PMID: 9915437.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    238. Corral DA, Sella A, Pettaway CA, Amato RJ, Jones DM, Ellerhorst J. Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin. J Urol. 1998 Nov; 160(5):1770-4. PMID: 9783949.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    239. Zagars GK, Pollack A, Pettaway CA. Prostate cancer in African-American men: outcome following radiation therapy with or without adjuvant androgen ablation. Int J Radiat Oncol Biol Phys. 1998 Oct 01; 42(3):517-23. PMID: 9806509.
      Citations: 3     Fields:    Translation:Humans
    240. Pettaway CA, Troncoso P, Ramirez EI, Johnston DA, Steelhammer L, Babaian RJ. Prostate specific antigen and pathological features of prostate cancer in black and white patients: a comparative study based on radical prostatectomy specimens. J Urol. 1998 Aug; 160(2):437-42. PMID: 9679893.
      Citations: 28     Fields:    Translation:Humans
    241. Hall MC, Sanders JS, Vuitch F, Ramirez E, Pettaway CA. Deoxyribonucleic acid flow cytometry and traditional pathologic variables in invasive penile carcinoma: assessment of prognostic significance. Urology. 1998 Jul; 52(1):111-6. PMID: 9671880.
      Citations: 5     Fields:    Translation:Humans
    242. Pettaway CA. Prognostic markers in clinically localized prostate cancer. Tech Urol. 1998 Mar; 4(1):35-42. PMID: 9568775.
      Citations: 1     Fields:    Translation:Humans
    243. Westney OL, Pisters LL, Pettaway CA, Tu SM, Pollack A, Dinney CP. Presentation, methods of diagnosis and therapy for pelvic recurrence following radical cystectomy for transitional cell carcinoma of the bladder. J Urol. 1998 Mar; 159(3):792-5. PMID: 9474150.
      Citations: 10     Fields:    Translation:Humans
    244. Chen ME, Pisters LL, Malpica A, Pettaway CA, Dinney CP. Risk of urethral, vaginal and cervical involvement in patients undergoing radical cystectomy for bladder cancer: results of a contemporary cystectomy series from M. D. Anderson Cancer Center. J Urol. 1997 Jun; 157(6):2120-3. PMID: 9146596.
      Citations: 16     Fields:    Translation:Humans
    245. Greene GF, Kitadai Y, Pettaway CA, von Eschenbach AC, Bucana CD, Fidler IJ. Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. Am J Pathol. 1997 May; 150(5):1571-82. PMID: 9137084; PMCID: PMC1858224.
      Citations: 38     Fields:    Translation:HumansAnimalsCells
    246. Pisters LL, von Eschenbach AC, Scott SM, Swanson DA, Dinney CP, Pettaway CA, Babaian RJ. The efficacy and complications of salvage cryotherapy of the prostate. J Urol. 1997 Mar; 157(3):921-5. PMID: 9072600.
      Citations: 28     Fields:    Translation:HumansCTClinical Trials
    247. McConkey DJ, Greene G, Pettaway CA. Apoptosis resistance increases with metastatic potential in cells of the human LNCaP prostate carcinoma line. Cancer Res. 1996 Dec 15; 56(24):5594-9. PMID: 8971161.
      Citations: 24     Fields:    Translation:HumansAnimalsCells
    248. Pettaway CA, Pathak S, Greene G, Ramirez E, Wilson MR, Killion JJ, Fidler IJ. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin Cancer Res. 1996 Sep; 2(9):1627-36. PMID: 9816342.
      Citations: 144     Fields:    Translation:HumansAnimalsCells
    249. Pettaway CA, Pisters LL, Dinney CP, Jularbal F, Swanson DA, von Eschenbach AC, Ayala A. Sentinel lymph node dissection for penile carcinoma: the M. D. Anderson Cancer Center experience. J Urol. 1995 Dec; 154(6):1999-2003. PMID: 7500444.
      Citations: 24     Fields:    Translation:Humans
    250. Delworth M, Nishioka K, Pettaway C, Gutman M, Killion J, Voneschenbach A, Fidler I. Systemic administration of 4-amidinoindanon-1-(2'-amidino)-hydrazone, a new inhibitor of s-adenosylmethionine decarboxylase, produces cytostasis of human prostate-cancer in athymic nude-mice. Int J Oncol. 1995 Feb; 6(2):293-9. PMID: 21556536.
      Citations: 8     Fields:    
    251. Moraes JR, Pettaway C, Stastny P. Prediction of early kidney transplant rejection by a crossmatch with donor skin. Transplantation. 1989 Dec; 48(6):951-2. PMID: 2688207.
      Citations: 2     Fields:    Translation:Humans
    252. Pettaway CA, Ball EJ, Stastny P. Allogeneic lymphocyte stimulation by human spleen. Identification of cells that are very effective for presenting class II HLA antigens. Transplantation. 1988 Dec; 46(6):874-8. PMID: 2974656.
      Citations:    Fields:    Translation:HumansCells
    253. Pettaway CA, Freeman C, Helderman JH, Stastny P. Kidney transplant recipients with long incubation-positive antiglobulin-negative T cell crossmatches. Transplantation. 1987 Oct; 44(4):529-33. PMID: 3313840.
      Citations:    Fields:    Translation:HumansCells
    254. Editorial Comment. Urology.
    255. CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment. Nature Communications. 7.
    256. Systemic administration of 4-amidinoindanon-1-(2'-amidino)-hydrazone, a new inhibitor of S-adenosylmethionine decarboxylase, produces cytostasis of human prostate cancer in athymic nude mice. International Journal of Oncology. 6:293-299.
    257. Prostate cancer. 35-43.
    258. Adenoid cystic carcinoma of the urethra/Cowper's gland with concurrent high-grade prostatic adenocarcinoma. Human Pathology. 58:138-144.
    259. Informed decision making before prostate-specific antigen screening. Cancer.
    260. Treatment decisions for localized prostate cancer. Health Expectations.
    261. Integrating chemohormonal therapy and surgery in known or suspected lymph node metastatic prostate cancer. Prostate Cancer and Prostatic Diseases. 18:276-280.
    262. Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation. Nature Communications. 7.
    263. Editorial comment. Journal of Urology. 168:2421.
    264. Surgical management of the clinically negative and locally advanced inguinal region in patients with squamous penile cancer. 153-171.
    265. Intraprostatic AD-p53 gene therapy followed by radical prostatectomy. Prostate Cancer and Prostatic Diseases. 2.
    266. Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions. Human Molecular Genetics. 24:5603-5618.
    267. Neoadjuvant Systemic Therapy before Radical Prostatectomy in High-Risk Prostate Cancer Does Not Increase Surgical Morbidity. Clinical Genitourinary Cancer. 14:130-138.
    268. Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy. Journal of Urology. 175:1365-1366.
    269. Factors associated with regional recurrence after lymph node dissection for penile squamous cell carcinoma. BJU International.
    270. Prostate cancer susceptibility in men of African ancestry at 8q24. Journal of the National Cancer Institute. 108.
    271. Reply. Urology.
    272. Impact of ethnicity on the outcome of men with metastatic, hormone-sensitive prostate cancer. Cancer.
    273. Editorial comment. International Braz J Urol. 33:65.
    274. Editorial Comment. Journal of Urology. 176:1414.
    275. Development of orthotopic models of metastatic human prostate cancer. Cancer Bulletin. 45:424-429.
    276. Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate Cancer. EBioMedicine.
    277. Enhanced invasion of hormone refractory prostate cancer cells through hepatocyte growth factor (HGF) induction of urokinase-type plasminogen activator (u-PA). Urologic Oncology: Seminars and Original Investigations. 23:74.
    278. Disparities in penile cancer. Cancer Control. 23:409-414.
    279. Whole-exome sequencing of over 4100 men of African ancestry and prostate cancer risk. Human Molecular Genetics. 25:371-381.
    280. Robotic-assisted laparoscopic versus open salvage radical prostatectomy following radiotherapy. Canadian Journal of Urology. 23:8271-8277.
    281. Prostate Cancer Education, Detection, and Follow-Up in a Community-Based Multiethnic Cohort of Medically Underserved Men. American Journal of Men's Health. 11:82-91.
    282. Urology. 96:116-120.
    283. Two susceptibility loci identified for prostate cancer aggressiveness. Nature Communications. 6.
    PETTAWAY's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (668)
    Explore
    _
    Co-Authors (142)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _